7834 |
P0AE07 |
AF NFT |
Multidrug efflux pump subunit AcrA |
>sp|P0AE07|ACRA_ECO57 Multidrug efflux pump subunit AcrA OS=Escherichia coli O157:H7 OX=83334 GN=acrA PE=3 SV=1 MNKNRGFTPLAVVLMLSGSLALTGCDDKQAQQGGQQMPAVGVVTVKTEPLQITTELPGRTSAYRIAEVRPQVSGIILKRNFKEGSDIEAGVSLYQIDPATYQATYDSAKGDLAKAQAAANIAQLTVNRYQKLLGTQYISKQEYDQALADAQQANAAVTAAKAAVETARINLAYTKVTSPISGRIGKSNVTEGALVQNGQATALATVQQLDPIYVDVTQSSNDFLRLKQELANGTLKQENGKAKVSLITSDGIKFPQDGTLEFSDVTVDQTTGSITLRAIFPNPDHTLLPGMFVRARLEEGLNPNAILVPQQGVTRTPRGDATVLVVGADDKVETRPIVASQAIGDKWLVTEGLKAGDRVVISGLQKVRPGVQVKAQEVTADNNQQAASGAQPEQSKS |
7834 |
HLA08055 DRB1*09:01:09 |
HLA NFT |
DRB1*09:01:09 |
>HLA:HLA08055 DRB1*09:01:09 89 bp RFLKQDKFECHFFNGTERVRYLHRGIYNQEENVRFDSDVGEYRAVTELGRPVAESWNSQKDFLERRRAEVDTVCRHNYGVGESFTVQRR |
7835 |
HLA08056 A*02:01:79 |
HLA NFT |
A*02:01:79 |
>HLA:HLA08056 A*02:01:79 273 bp SHSMRYFFTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWIEQEGPEYWDGETRKVKAHSQTHRVDLGTLRGYYNQSEAGSHTVQRMYGCDVGSDWRFLRGYHQYAYDGKDYIALKEDLRSWTAADMAAQTTKHKWEAAHVAEQLRAYLEGTCVEWLRRYLENGKETLQRTDAPKTHMTHHAVSDHEATLRCWALSFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWAAVVVPSGQEQRYTCHVQHEGLPKPLTLRW |
7835 |
P0AE06 |
AF NFT |
Multidrug efflux pump subunit AcrA |
>sp|P0AE06|ACRA_ECOLI Multidrug efflux pump subunit AcrA OS=Escherichia coli (strain K12) OX=83333 GN=acrA PE=1 SV=1 MNKNRGFTPLAVVLMLSGSLALTGCDDKQAQQGGQQMPAVGVVTVKTEPLQITTELPGRTSAYRIAEVRPQVSGIILKRNFKEGSDIEAGVSLYQIDPATYQATYDSAKGDLAKAQAAANIAQLTVNRYQKLLGTQYISKQEYDQALADAQQANAAVTAAKAAVETARINLAYTKVTSPISGRIGKSNVTEGALVQNGQATALATVQQLDPIYVDVTQSSNDFLRLKQELANGTLKQENGKAKVSLITSDGIKFPQDGTLEFSDVTVDQTTGSITLRAIFPNPDHTLLPGMFVRARLEEGLNPNAILVPQQGVTRTPRGDATVLVVGADDKVETRPIVASQAIGDKWLVTEGLKAGDRVVISGLQKVRPGVQVKAQEVTADNNQQAASGAQPEQSKS |
7835 |
1GIM |
PDB NFT |
CRYSTAL STRUCTURE OF ADENYLOSUCCINATE SYNTHETASE FROM ESCHERICHIA COLI COMPLEXED WITH GDP, IMP, HADACIDIN, NO3-, AND MG2+. DATA COLLECTED AT 100K (PH 6.5) |
>1gim_A mol:protein length:431 ADENYLOSUCCINATE SYNTHETASE
GNNVVVLGTQWGDEGKGKIVDLLTERAKYVVRYQGGHNAGHTLVINGEKTVLHLIPSGILRENVTSIIGNGVVLSPAALMKEMKELEDRGIPVRERLLLSEACPLILDYHVALDNAREKARGAKAIGTTGRGIGPAYEDKVARRGLRVGDLFDKETFAEKLKEVMEYHNFQLVNYYKAEAVDYQKVLDDTMAVADILTSMVVDVSDLLDQARQRGDFVMFEGAQGTLLDIDHGTYPYVTSSNTTAGGVATGSGLGPRYVDYVLGILKAYSTRVGAGPFPTELFDETGEFLCKQGNEFGATTGRRRRTGWLDTVAVRRAVQLNSLSGFCLTKLDVLDGLKEVKLCVAYRMPDGREVTTTPLAADDWKGVEPIYETMPGWSESTFGVKDRSGLPQAALNYIKRIEELTGVPIDIISTGPDRTETMILRDPFDA |
7836 |
1GIN |
PDB NFT |
CRYSTAL STRUCTURE OF ADENYLOSUCCINATE SYNTHETASE FROM ESCHERICHIA COLI COMPLEXED WITH GDP, IMP, HADACIDIN, NO3-, AND MG2+. DATA COLLECTED AT 298K (PH 6.5). |
>1gin_A mol:protein length:431 ADENYLOSUCCINATE SYNTHETASE
GNNVVVLGTQWGDEGKGKIVDLLTERAKYVVRYQGGHNAGHTLVINGEKTVLHLIPSGILRENVTSIIGNGVVLSPAALMKEMKELEDRGIPVRERLLLSEACPLILDYHVALDNAREKARGAKAIGTTGRGIGPAYEDKVARRGLRVGDLFDKETFAEKLKEVMEYHNFQLVNYYKAEAVDYQKVLDDTMAVADILTSMVVDVSDLLDQARQRGDFVMFEGAQGTLLDIDHGTYPYVTSSNTTAGGVATGSGLGPRYVDYVLGILKAYSTRVGAGPFPTELFDETGEFLCKQGNEFGATTGRRRRTGWLDTVAVRRAVQLNSLSGFCLTKLDVLDGLKEVKLCVAYRMPDGREVTTTPLAADDWKGVEPIYETMPGWSESTFGVKDRSGLPQAALNYIKRIEELTGVPIDIISTGPDRTETMILRDPFDA |
7836 |
Q60485 |
AF NFT |
Acrosin-binding protein |
>sp|Q60485|ACRBP_CAVPO Acrosin-binding protein OS=Cavia porcellus OX=10141 GN=ACRBP PE=2 SV=1 MGQPAAGSILTLLRVLLLPLGPALAQDSPSAPTPGSPLSPTEYERFFALLTPTWKAETTCRLRATHGCRNPTIVQLDQYENHGLVPDGAVCSDLPYASWFESFCQFSQYRCSNHVYYAKRVRCSQPVSILSVNSFKELESPVEVSPTTMTSPVTSHIKATERQSFQAWPERLSNNVEELLQSSLSLAGQEQAAGHKQEQGQEQHKQDPTQEHKQDDGQEQEEQEEEQEEEGKQEEGQSVEDMLGRVGRAGLRIGSEPKPQSLSLSSDPHSFTARVRDVDSAPMMIENIQELIQSAQEMEEMYEEDAYWRSQNHGSLLQLPHKEALLVLCYSIVMNSCVMTPSAKAWKYLEEETFGFGKSVCDNLGRRHMALCPLCAFCSLKLEQCHSEANLQRQQCDASHKTPFISSLLTAQTMSMGTQAGTSESGRFYGLDVYGGLRMDFWCARLATKGCEDIRVSSWLQTEFLSFHNGDFPTKVCDTDYIQYPNYCSFKSQQCLMKNRNRKVSRMRCMQNETYNVLTPSKGEDLVLRWSQEFSTLALSRFG |
7836 |
HLA08057 A*68:93 |
HLA NFT |
A*68:93 |
>HLA:HLA08057 A*68:93 181 bp SHSMRYFYTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWIEQEGPEYWDRNTRNVKAQSQTDRVDLGTLRGYYNQSEGGSHTIQMMYGCDVGSDGRFLRGYRQDAYDGKDYIALKEDLRSWTAADMAAQTTKHKWEAAHVAEQWRAYLEGTCVEWLRRYLENGKETLQRT |
7837 |
HLA08058 B*13:58 |
HLA NFT |
B*13:58 |
>HLA:HLA08058 B*13:58 181 bp SHSMRYFYTAMSRPGRGEPRFITVGYVDDTQFVRFDSDAASPRTEPRAPWIEQEGPEYWDRETQISKTNTQTYRENLRTALRYYNQSEAGSHTWQTMYGCDLGPDGRLLRGHNQLAYDGKDYIALNEDLSSWTAADTAAQITQLKWEAARVAEQLRAYLEGECVEWLRRYLENGKETLQRA |
7837 |
Q8NEB7 |
AF NFT |
Acrosin-binding protein |
>sp|Q8NEB7|ACRBP_HUMAN Acrosin-binding protein OS=Homo sapiens OX=9606 GN=ACRBP PE=2 SV=1 MRKPAAGFLPSLLKVLLLPLAPAAAQDSTQASTPGSPLSPTEYERFFALLTPTWKAETTCRLRATHGCRNPTLVQLDQYENHGLVPDGAVCSNLPYASWFESFCQFTHYRCSNHVYYAKRVLCSQPVSILSPNTLKEIEASAEVSPTTMTSPISPHFTVTERQTFQPWPERLSNNVEELLQSSLSLGGQEQAPEHKQEQGVEHRQEPTQEHKQEEGQKQEEQEEEQEEEGKQEEGQGTKEGREAVSQLQTDSEPKFHSESLSSNPSSFAPRVREVESTPMIMENIQELIRSAQEIDEMNEIYDENSYWRNQNPGSLLQLPHTEALLVLCYSIVENTCIITPTAKAWKYMEEEILGFGKSVCDSLGRRHMSTCALCDFCSLKLEQCHSEASLQRQQCDTSHKTPFVSPLLASQSLSIGNQVGSPESGRFYGLDLYGGLHMDFWCARLATKGCEDVRVSGWLQTEFLSFQDGDFPTKICDTDYIQYPNYCSFKSQQCLMRNRNRKVSRMRCLQNETYSALSPGKSEDVVLRWSQEFSTLTLGQFG |
7837 |
1GIO |
PDB NFT |
NMR SOLUTION STRUCTURE OF BOVINE ANGIOGENIN, 10 STRUCTURES |
>1gio_A mol:protein length:125 ANGIOGENIN
AQDDYRYIHFLTQHYDAKPKGRNDEYCFNMMKNRRLTRPCKDRNTFIHGNKNDIKAICEDRNGQPYRGDLRISKSEFQITICKHKGGSSRPPCRYGATEDSRVIVVGCENGLPVHFDESFITPRH |
7838 |
1GIP |
PDB NFT |
THE NMR STRUCTURE OF DNA DODECAMER DETERMINED IN AQUEOUS DILUTE LIQUID CRYSTALLINE PHASE |
>1gip_A mol:na length:12 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3'
CGCGAATTCGCG
>1gip_B mol:na length:12 5'-D(*CP*GP*CP*GP*AP*AP*TP*TP*CP*GP*CP*G)-3'
CGCGAATTCGCG |
7838 |
Q3V140 |
AF NFT |
Acrosin-binding protein |
>sp|Q3V140|ACRBP_MOUSE Acrosin-binding protein OS=Mus musculus OX=10090 GN=Acrbp PE=1 SV=1 MMNLAAGFLLMLLEVLLLPGTPLSAEESPASTPGSPLSSTEYERFFALLTPTWKAETTCRLRATHGCRNPTLVQLDQYENHGLVPDGAVCSDLPYASWFESFCQFAQYRCSNHVYYAKRVRCSQPVSILSPNTLKEVESSAEVPPTSMTTPIVSHATATEHQAFQPWPERLNNNVEELLQSSLSLGGKDQQSSRRPGQEQRKQEQIQEHKLEEAQEQEEQEEEEEEEEAKQEEGQGTEAGLESVSRLQSDSEPKFQSQSLSSNPSFFTPRVREVESAPLMMKNIQELIRSAQEMDEMNELYDDSWRSQSTGSLQQLPHMETLMVLCYSIMENTCTMTPTAKAWSYMEEEILGFGDSVCDNLGRRHTAACPLCAFCSLKLEQCHSEASVLRQKCDASHKIPFISPLLSAQSISTGNQARIPDKGRFAGLEMYGGLSSEFWCNRLAMKGCEDDRVSNWLKAEFLSFQEGDFPTKICDTNYIQYPNYCSFKSQQCLLRNQNRKMSRMRCMLNERYNVLSLAKSEEVILRWSQEFSTLAIGQFG |
7838 |
HLA08059 B*56:36 |
HLA NFT |
B*56:36 |
>HLA:HLA08059 B*56:36 181 bp SHSMRYFYTAMSRPGRGEPRFITVGYVDDTQFVRFDSDAASPREEPRAPWIEQEGPEYWDRNTQIYKAQAQTDRESLRNLRGYYNQSEAGSHTWQTMYGCDLGPDGRLLRGHNQLAYDGKDYIALNEDLSSWTAADTAAQITQRKWEAARVAEQLRAYLEGLCVEWLRRYLENGKETLQRA |
7839 |
HLA08060 B*44:153 |
HLA NFT |
B*44:153 |
>HLA:HLA08060 B*44:153 181 bp SHSMRYFYTAMSRPGRGEPRFITVGYVDDTLFVRFDSDATSPRKEPRAPWIEQEGPEYWDRETQISKTNTQTYRENLRTALRYYNQSEAGSHIIQVMYGCDVGPDGRLLRGYDQDAYDGKDYIALNEDLSSWTAADTAAQITQRKWEAARVAEQLRAYLEGLCVESLRRYLENGKETLQRA |
7839 |
Q29016 |
AF NFT |
Acrosin-binding protein |
>sp|Q29016|ACRBP_PIG Acrosin-binding protein OS=Sus scrofa OX=9823 GN=ACRBP PE=1 SV=2 MRQLAAGSLLSLLKVLLLPLAPAPAQDANSASTPGSPLSPTEYERFFALLTPTWKAETTCRLRATHGCRNPTLVQLDQYENHGLVPDGAVCSDLPYASWFESFCQFTQYRCSNHVYYAKRVRCSQPVSILSPNSLKEVDTSSEVPITTMTSPVSSHITATGRQVFQPWPERLNNNVEELLQSSLSLGGQEQGQEHKQEHKQEQGQEHKQDEGQEQEEQEEEQEEEGKQEEGQGTEESLEAMSGLQADSEPKFQSEFVSSNPFSFTPRVREVESTPMMMENIQELIRSAQEMDEMGDVYEEENIWRAQSPGSLLQLPHVDALLVLCYSIVENTCVITPTAKAWQYLEDETLGFGKSVCDSLGRRHLAACSLCDFCSLKLEQCHSETNLQRQQCDNSHKTPFISPLLASQSMSIGTQIGTLKSGRFYGLDLYGGLRMDFWCARLATKGCEDNRVASWLQTEFLSFQDGDFPTKICDTEYVQYPNYCAFKSQQCMMRNRDRKVSRMRCLQNETYTVLTQAKSEDLVLRWSQEFSTLTLGQAG |
7839 |
1GIQ |
PDB NFT |
Crystal Structure of the Enzymatic Componet of Iota-Toxin from Clostridium Perfringens with NADH |
>1giq_A mol:protein length:413 IOTA TOXIN COMPONENT IA
AFIERPEDFLKDKENAIQWEKKEAERVEKNLDTLEKEALELYKKDSEQISNYSQTRQYFYDYQIESNPREKEYKNLRNAISKNKIDKPINVYYFESPEKFAFNKEIRTENQNEISLEKFNELKETIQDKLFKQDGFKDVSLYEPGNGDEKPTPLLIHLKLPKNTGMLPYINSNDVKTLIEQDYSIKIDKIVRIVIEGKQYIKAEASIVNSLDFKDDVSKGDLWGKENYSDWSNKLTPNELADVNDYMRGGYTAINNYLISNGPLNNPNPELDSKVNNIENALKLTPIPSNLIVYRRSGPQEFGLTLTSPEYDFNKIENIDAFKEKWEGKVITYPNFISTSIGSVNMSAFAKRKIILRINIPKDSPGAYLSAIPGYAGEYEVLLNHGSKFKINKVDSYKDGTVTKLILDATLIN
>1giq_B mol:protein length:413 IOTA TOXIN COMPONENT IA
AFIERPEDFLKDKENAIQWEKKEAERVEKNLDTLEKEALELYKKDSEQISNYSQTRQYFYDYQIESNPREKEYKNLRNAISKNKIDKPINVYYFESPEKFAFNKEIRTENQNEISLEKFNELKETIQDKLFKQDGFKDVSLYEPGNGDEKPTPLLIHLKLPKNTGMLPYINSNDVKTLIEQDYSIKIDKIVRIVIEGKQYIKAEASIVNSLDFKDDVSKGDLWGKENYSDWSNKLTPNELADVNDYMRGGYTAINNYLISNGPLNNPNPELDSKVNNIENALKLTPIPSNLIVYRRSGPQEFGLTLTSPEYDFNKIENIDAFKEKWEGKVITYPNFISTSIGSVNMSAFAKRKIILRINIPKDSPGAYLSAIPGYAGEYEVLLNHGSKFKINKVDSYKDGTVTKLILDATLIN |
7840 |
1GIR |
PDB NFT |
CRYSTAL STRUCTURE OF THE ENZYMATIC COMPONET OF IOTA-TOXIN FROM CLOSTRIDIUM PERFRINGENS WITH NADPH |
>1gir_A mol:protein length:413 IOTA TOXIN COMPONENT IA
AFIERPEDFLKDKENAIQWEKKEAERVEKNLDTLEKEALELYKKDSEQISNYSQTRQYFYDYQIESNPREKEYKNLRNAISKNKIDKPINVYYFESPEKFAFNKEIRTENQNEISLEKFNELKETIQDKLFKQDGFKDVSLYEPGNGDEKPTPLLIHLKLPKNTGMLPYINSNDVKTLIEQDYSIKIDKIVRIVIEGKQYIKAEASIVNSLDFKDDVSKGDLWGKENYSDWSNKLTPNELADVNDYMRGGYTAINNYLISNGPLNNPNPELDSKVNNIENALKLTPIPSNLIVYRRSGPQEFGLTLTSPEYDFNKIENIDAFKEKWEGKVITYPNFISTSIGSVNMSAFAKRKIILRINIPKDSPGAYLSAIPGYAGEYEVLLNHGSKFKINKVDSYKDGTVTKLILDATLIN |
7840 |
Q6AY33 |
AF NFT |
Acrosin-binding protein |
>sp|Q6AY33|ACRBP_RAT Acrosin-binding protein OS=Rattus norvegicus OX=10116 GN=Acrbp PE=2 SV=2 MKLAASFLLMLLEVLLLPETPLSAEEALASTPGSPLSSTEYERFFALLTPTWKAETTCRLRATHGCRNPTLVQLDQYENHGLVPDGAVCSDLPYASWFESFCQFAQYRCSNHVYYAKRVRCSQPVSILSPNTLKEVESSAEVPLTSVTTPIVSRATATEHQAFQPWPERLNNNVEELLQSSLSLGGKEQQSSRKLGLEQQHKQEQIQEHKLEEAQEQEEQEEEEEEEEAKQEEGQGTEEGLDSVSRLQSDSEPKFQSKSLSSNPSFFTPRVREVESAPLMMENIQELIRSAQEMDEMNELYDDSWRSQSTGSLQQLPHTETLMVLCYSIMENTCTMTPTAKAWSYMEEEILGFGDSVCDNLGRRHTAACPLCAFCSLKLEQCHSEASVLRQQCDASHKIPFISPLLSAQSISTGNQAKIPEKGRFAGLEMYGGLSSEFWCNRLALKGCEDDRVANWLKAEFLSFQDGDLPTKICDTNYVQYPNYCSFKSQQCLLKNQNRKMSRMKCMLNEKYHVLSPAKGEEVILRWSQEFNTLTLGQFG |
7840 |
HLA08061 B*44:154 |
HLA NFT |
B*44:154 |
>HLA:HLA08061 B*44:154 181 bp SHSMRYFYTAMSRPGRGEPRFITVGYVDDTLFVRFDSDATSPRKEPRAPWIEQEGPEYWDRETQISKTNTQTYGENLRTALRYYNQSEAGSHIIQRMYGCDVGPDGRLLRGYDQDAYDGKDYIALNEDLSSWTAADTAAQITQRKWEAARVAEQLRAYLEGLCVESLRRYLENGKETLQRA |
7841 |
HLA08062 B*35:204 |
HLA NFT |
B*35:204 |
>HLA:HLA08062 B*35:204 181 bp SHSMRYFYTAMSRPGRGEPRFIAVGYVDDTQFVRFDSDAASPRTEPRAPWIEQEGPEYWDRNTQIFKTNTQTYRESLRNLRGYYNQSEAGSHIIQRMYGCDLGPDGRLLRGHDQFAYDGKDYIALNEDLSSWTAADTAAQITQRKWEAARVAEQLRAYLEGLCVEWLLRYLENGKETLQRA |
7841 |
A0A1L9WR63 |
AF NFT |
Nonribosomal peptide synthetase acrB |
>sp|A0A1L9WR63|ACRB_ASPA1 Nonribosomal peptide synthetase acrB OS=Aspergillus aculeatus (strain ATCC 16872 / CBS 172.66 / WB 5094) OX=690307 GN=acrB PE=2 SV=1 MIMTANNDMAVRESVVVTEGASSTPELWQMLGSRDQPTNITPRVRITDVDHKQLHSSANLVSARALQQLTKSLHEGICSTALEDDSQSSSAYYSTYASTPRSLSPNLEAVPSDDGIPDLQPQFEAVERASFAQERIWFLHEYLTDPTTFNVTMAYAVQGPLQPAELATAFRAMSDRHESLRTAFFLDSRDGEPQLFQGILPETQIEISIHTIDSTQVVDEVYASVRDHVYDLPRGKTMKVAILTLTPTTHFLVLGFHHIALDGFSAQIFIKDLQLIYSTGQILPPAPRYRDYTLLQRQSLANDTYRESLDFWKSKLANLPPPMPLFAFSRVAARKPLNSYRVHSVERTIGISLASKIKDTAHKVGGTTSFFLYLTALRELVFRLLGHAQRDICLGISDAGRADKEALQVVGMFVNMLPLQFRAARPGQSFRDLLATTTRQVRTALTHAAVPYQVLLDELAVQRSPSENPLFQILLNYKMGSTEEATLGHCRAHSLRMDDARTGLDLVIEVEEFVDGNFQVAVRGQEYLYGEEGLEFILSSLVTILEEVTLRPSMPVANLAIFDEKSITHALELSRGEHVFTAEHLLTVVHLFDRHCKAHPRDVAVKQADGQFLSYGELQGRAQELARRLQELEGSTAVVVACKPSLDTIVSIVGIHYAGCTYVPVDIEHPEERLRTIVEDCKPRAILYHADTQDLAVALAGGAIAVPTPQSGMDKAFPIKASVNDTAYILYTSGSTGKPKGVIVSHGNLTCQILSMRRTATLGKETVLHQSGVAFDASIDCVYAALAGQGTLVMAPPEVRRDPVQLASLMAREQITYTQMTSSEYHNLVVYGAEHLKQCVTYRNAFCGGEKFLSSLIPLFRALELPALRVWNRYGPTEITVSSSMQMIVGADGLNRSTELIPCGRPLTNYSVFILDEQRRPVPAGVPGEICIGGGGVAQGYLNNARLTASKFVKNIYASEDDVRRGWDRLYRTGDRGYLLSDGSLVFLGRMEGSAQVKIRGQRVELDEIETAIVATSEGRVLSAGVCVKGDNADAVLAAYVVLRPDVQVDSLSSLVASLARSLPLPRYMRPSSFVAVGRLPHNTSGKLDRQALSKLSGTPIAIETNNHPAPLGVEEEVMAKAWREVLPGEAVLSAESNFFDVGGNSLLLVRLQKVIEELTGKSVALTELFSTPGMSAMARLLQPQEATRETTEVDWESETQLTPSLLSAIQTSSRCSPSSEVEVILTGATGFLGRTLLQQLLAHPRIAHVHCLAIRNSSVTRASLTSNPDHAAKLTLYHGDLSHPTLSLNEETISSLSNRIGLVIHNGASVSFLKSYSTLRAPNVHSSRFLLQLSIERGIPFHFVSTGGVVNLTGQPTWPPVSVRNYPPPGEQGYIASKWASERLIENAAEALHLRGVHLPVVVHRPASIVARQPGTPGTSQSEPPAMDIMHNMVQYARIMQCFPATEGVNWRFDFVGVDAVASGILASALGEEDESEGVKYVHHCNERKLSPRELKKELEEEAGCVFEEVEVGEWVRRAKECGMDGLVAATLVDLMERQRGVVFTEMGLDC |
7841 |
1GIS |
PDB NFT |
A TRICHOSANTHIN(TCS) MUTANT(E85Q) COMPLEX STRUCTURE WITH 2'-DEOXY-ADENOSIN-5'-MONOPHOSPHATE |
>1gis_A mol:protein length:248 RIBOSOME-INACTIVATING PROTEIN ALPHA-TRICHOSANTHIN
MDVSFRLSGATSSSYGVFISNLRKALPNERKLYDIPLLRSSLPGSQRYALIHLTNYADETISVAIDVTNVYIMGYRAGDTSYFFNQASATEAAKYVFKDAMRKVTLPYSGNYERLQTAAGKIRENIPLGLPALDSAITTLFYYNANSAASALMVLIQSTSEAARYKFIEQQIGKRVDKTFLPSLAIISLENSWSALSKQIQIASTNNGQFESPVVLINAQNQRVTITNVDAGVVTSNIALLLNRNNMA |
7842 |
1GIT |
PDB NFT |
STRUCTURE OF GTP-BINDING PROTEIN |
>1git_A mol:protein length:353 G PROTEIN GI ALPHA 1
GCTLSAEDKAAVERSKMIDRNLREDGEKAAREVKLLLLGAGESGKSTIVKQMKIIHEAGYSEEECKQYKAVVYSNTIQSIIAIIRAMGRLKIDFGDAARADDARQLFVLAGAAEEGFMTAELAGVIKRLWKDSGVQACFNRSREYQLNDSAAYYLNDLDRIAQPNYIPTQQDVLRTRVKTTGIVETHFTFKDLHFKMFDVGAQRSERKKWIHCFEGVTAIIFCVALSDYDLVLAEDEEMNRMHESMKLFDSICNNKWFTDTSIILFLNKKDLFEEKIKKSPLTICYPEYAGSNTYEEAAAYIQCQFEDLNKRKDTKEIYTHFTCATDTKNVQFVFDAVTDVIIKNNLKDCGLF |
7842 |
A1CIK0 |
AF NFT |
Probable ubiquitination network signaling protein acrB |
>sp|A1CIK0|ACRB_ASPCL Probable ubiquitination network signaling protein acrB OS=Aspergillus clavatus (strain ATCC 1007 / CBS 513.65 / DSM 816 / NCTC 3887 / NRRL 1 / QM 1276 / 107) OX=344612 GN=acrB PE=3 SV=1 MPRSSATARKNQSNRNENGASSGKKVAKQKSNGHLNGSLNGGSTPGSVSSSQVDLPSSRSTSDSAIAPAAAASSNLNGISDSSKEDCNGREKLNGYTKGNADMSYVQTNGAGSQNGGDHAGQASHRTDKSATGAKRSTSNASINPLQLASTILKSCPMYDTIAILIFLLQLPPMVLTLVQFLFASLTFMPPSGASAGSLSSNFDIFQGPAGTPSLSTMIAMDGFCLLIWALLMWTWAQNFALDLAHVQVAITLGGGGSGKNGGVNTLCVGIVLILHLIRSKGIQDFVIGHLLSSNIISPDLLAQYSHLLPTEFRRTESQTSPSWIRSLLAVHILAQAGTAMARRSMAKNRSPNPPRPGKRVDTEASAGSQTQIDSAFESGASVSSYLGPDGQLITPTAHKDGRDRLLSAKKRRRQANQVRSRQPFWAALASTKVTVMREYEHSRALSKTARGLPMTENDLQGVSFDDGLVWITDVDASTIKFAAGDFASADDSGLSGACEDGRLGNEEIEPFYVCVNGALWATATISRVPDAQKGSGMVHWRGEVSGLAPNCAYTCSFMRSDTDEEICAISVKTPVTNDTEQFSLVSPPPQPSYRPSSPTTTLKNSIVNAEAKLNEKRSRLRKAKNDHKLIISKIRKELDNYNHRLHSGTDENRQKQRSLQLERNIRQTEEATALLEGQLDSLENIPEEELREWSDQKAKYDQELQLLNSAKEELVSARSAVAREVSSLESDLGSTVQRRERLQSRRTRVNEQYERIVSANAQGLNERERRAAEQFAREQDQAKLEANFNEQFGSIGQSVQEYQLRAQQIWQQCDAIEQAIQQQQQRMLLDSAPLTPEGNLPGTNPFSETSALPLGALTSTAPNSRSLLGLSFPAIKSSPLQTISSALDASSSHPTSPVQPPSFLNFPASPLVNATSHLDSDFTYRDRSFSNRSARSSLYGSEFLDSSRRQPFQIDLPELLGEKRNSGSDSTALKSGLRPVSSPFQRAGSRGSGSGSNGSGGSGSGSGSPSSAYGKPN |
7842 |
HLA08063 B*35:205:01 |
HLA NFT |
B*35:205:01 |
>HLA:HLA08063 B*35:205:01 181 bp SHSMRYFYTAMSRPGRGEPRFIAVGYVDDTQFVRFDSDAASPRTEPRAPWIEQEGPEYWDRNTQIFKTNTQTYRESLRNLRGYYNQSEAGSHIIQRMYGCDLGPDGRLLRGHDQFAYDGKDYIALNEDLRSWTAADTAAQITQRKWEAARVAEQLRAYLEGLCVEWLRRYLENGKETLQRA |
7843 |
HLA08064 B*52:30 |
HLA NFT |
B*52:30 |
>HLA:HLA08064 B*52:30 181 bp SHSMRYFYTAMSRPGRGEPRFIAVGYVDDTQFVRFDSDAASPRTEPRAPWIEQEGPEYWDRETQISKTNTQTYRENLRIALRYYNQSEAGSHTWQTMYGCDVGPDGRLLRGHNQYAYDGKDYIALNEDLSSWTTADTAAQITQRKWEAAREAEQLRAYLEGLCVEWLRRHLENGKETLQRA |
7843 |
B0Y4N5 |
AF NFT |
Probable ubiquitination network signaling protein acrB |
>sp|B0Y4N5|ACRB_ASPFC Probable ubiquitination network signaling protein acrB OS=Neosartorya fumigata (strain CEA10 / CBS 144.89 / FGSC A1163) OX=451804 GN=acrB PE=3 SV=1 MPRSSATARKSHSNRHENGSANTGKKVAKQKSNGHLNGNLNGGSASSSLSSSQVDLPSSRSSSDPVVPTTTAASTKLNGTPDSSKGDCNAPDHLNGYAKGNADMSYVQNDGVASQTGGDVAGPASRRTEKSATGSKRSPSNASVNPLQLASTILKSCPMYDTIAILIFLLQLPPMVLTLVQFLFASLTFLPPSGASAGSLTSNFDIFQGPAGTPSLGTMIAMDGFCLLIWGLFMWTWAQNFALDLAHVQVAITLGGGGFGKNGGVNTLCVGIVLIMHLVRSKGIQDFVIGHLLSSNIISPDMLSQYSHLLPTEFRRTEPQTSPSWLRSLLAVHILAQAGTAMARRSMAKNRTPNPPRTGKRIDTEASAGSQTQIDSAFESGASVSSYIGADGQIVTSAAHKDGRDRLLSAKKRRRQANQVRSRQPFWAALASTKITVMREYEHSRALSKTARSLPMTEDDLQGLSLDDGLVWITEIDSSTIKFAAGDFSSADDSSGSGACEAGCLGSEDMEPFYVCVNGALWATATICKVHDAPKGSSMVHWRGEISGLAPNCAYTCSFVRSDTDEEICVISVKTPANNDAEQVSSVSTPPHPSYRPSSPTTTLKNSIVNAEAKLNEKRSRLRKAKNDHKLIISKIRKELDNYNHRLHSGTDENRQKQRSLQLERNIRQTEEATALLEDQLDNLENVPEEELRKWSDQKAKYEHELGLLNSAKEELASARSAIAREVSSLETELSSAIQRRERLQSRRTRINEQYERIVSANAQGLNERERRAAEQFAREQDQAKLEATFNEQFATIGQSVQEYQLRAQQIWQQCDAIEQAIQQQHQQMLLDPGPLTPEGNLPGTNPFSESALPLGALTSTAPSSRSLLGLSFPPLKSSPLQTASSPVGASSSHPTSPVQQPSYLNFPTSPLVNASSHLDSDFVYRHRSFSNRSARSSLYGSDFMDSSRRQPFQLDLSELLADKRSPGSDSNTALNSGLRPVSSPFQRAGSRGSGSGSNGSGGSGSGSGSPSSVYGKTN |
7843 |
1GIU |
PDB NFT |
A TRICHOSANTHIN(TCS) MUTANT(E85R) COMPLEX STRUCTURE WITH ADENINE |
>1giu_A mol:protein length:247 RIBOSOME-INACTIVATING PROTEIN ALPHA-TRICHOSANTHIN
DVSFRLSGATSSSYGVFISNLRKALPNERKLYDIPLLRSSLPGSQRYALIHLTNYADETISVAIDVTNVYIMGYRAGDTSYFFNRASATEAAKYVFKDAMRKVTLPYSGNYERLQTAAGKIRENIPLGLPALDSAITTLFYYNANSAASALMVLIQSTSEAARYKFIEQQIGKRVDKTFLPSLAIISLENSWSALSKQIQIASTNNGQFESPVVLINAQNQRVTITNVDAGVVTSNIALLLNRNNMA |
7844 |
1GIW |
PDB NFT |
SOLUTION STRUCTURE OF REDUCED HORSE HEART CYTOCHROME C, NMR, MINIMIZED AVERAGE STRUCTURE |
>1giw_A mol:protein length:104 CYTOCHROME C
GDVEKGKKIFVQKCAQCHTVEKGGKHKTGPNLHGLFGRKTGQAPGFTYTDANKNKGITWKEETLMEYLENPKKYIPGTKMIFAGIKKKTEREDLIAYLKKATNE |
7844 |
Q4WQG9 |
AF NFT |
Probable ubiquitination network signaling protein acrB |
>sp|Q4WQG9|ACRB_ASPFU Probable ubiquitination network signaling protein acrB OS=Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100) OX=330879 GN=acrB PE=3 SV=1 MPRSSATARKSHSNRHENGSANTGKKVAKQKSNGHLNVNLNGGSASSSLSSSQVDLPSSRSSSDPVVPTTTAASTKLNGTPDSSKGDCNAPDHLNGYAKGNADMSYVQNDGVASQTGGDVAGPASRRTEKSATGSKRSPSNASVNPLQLASTILKSCPMYDTIAILIFLLQLPPMVLTLVQFLFASLTFLPPSGASAGSLTSNFDIFQGPAGTPSLGTMIAMDGFCLLIWGLFMWTWAQNFALDLAHVQVAITLGGGGFGKNGGVNTLCVGIVLIMHLVRSKGIQDFVIGHLLSSNIISPDMLSQYSHLLPTEFRRTEPQTSPSWLRSLLAVHILAQAGTAMARRSMAKNRTPNPPRTGKRIDTEASAGSQTQIDSAFESGASVSSYIGADGQIVTSAAHKDGRDRLLSAKKRRRQANQVRSRQPFWAALASTKITVMREYEHSRALSKTARSLPMTEDDLQGLSLDDGLVWITEIDSSTIKFAAGDFSSADDSSGSGACEAGCLGSEDMEPFYVCVNGALWATATICKVHDAPKGSSMVHWRGEISGLAPNCAYTCSFVRSDTDEEICVISVKTPANNDAEQVSSVSTPPHPSYRPSSPTTTLKNSIVNAEAKLNEKRSRLRKAKNDHKLIISKIRKELDNYNHRLHSGTDENRQKQRSLQLERNIRQTEEATALLEDQLDNLENVPEEELRKWSDQKAKYEHELGLLNSAKEELASARSAIAREVSSLETELSSAIQRRERLQSRRTRINEQYERIVSANAQGLNERERRAAEQFAREQDQAKLEATFNEQFATIGQSVQEYQLRAQQIWQQCDAIEQAIQQQHQQMLLDPGPLTPEGNLPGTNPFSESALPLGALTSTAPSSRSLLGLSFPPLKSSPLQTASSPVGASSSHPTSPVQQPSYLNFPTSPLVNASSHLDSDFVYRHRSFSNRSARSSLYGSDFMDSSRRQPFQLDLSELLADKRSPGSDSNTALNSGLRPVSSPFQRAGSRGSGSGSNGSGGSGSGSGSPSSVYGKTN |
7844 |
HLA08065 B*52:01:12 |
HLA NFT |
B*52:01:12 |
>HLA:HLA08065 B*52:01:12 181 bp SHSMRYFYTAMSRPGRGEPRFIAVGYVDDTQFVRFDSDAASPRTEPRAPWIEQEGPEYWDRETQISKTNTQTYRENLRIALRYYNQSEAGSHTWQTMYGCDVGPDGRLLRGHNQYAYDGKDYIALNEDLSSWTAADTAAQITQRKWEAAREAEQLRAYLEGLCVEWLRRHLENGKETLQRA |
7845 |
HLA08066 B*53:28 |
HLA NFT |
B*53:28 |
>HLA:HLA08066 B*53:28 181 bp SHSMRYFYTAMSRPGRGEPRFIAVGYVDDTQFVRFDSDAASPRTEPRAPWIEQEGPEYWDRETQISKTNTQTYRENLRIALRYYNQSEAGSHIIQRMYGCDLGPDGRLLRGHDQSAYDGKDYIALNEDLSSWTAADTAAQITQRKWEAAREAEQLRAYLEGLCVEWLRRHLENGKETLQRA |
7845 |
A2Q9L8 |
AF NFT |
Probable ubiquitination network signaling protein acrB |
>sp|A2Q9L8|ACRB_ASPNC Probable ubiquitination network signaling protein acrB OS=Aspergillus niger (strain CBS 513.88 / FGSC A1513) OX=425011 GN=acrB PE=3 SV=2 MPRSSATARKSHSNRHENGLVGPGKKVNKQKSNGNLNGNTNGASAPNSGPSTQVDWPASRSSSDSALTSSATTASKVNGSADTSKADGNGRGLLNGYAKGNADMSYGQTNGAVPQNGGLAGQASRRTEKPATGSKKSGSINPLQLASTILKSCPMYDTIAILIFLLQLPPMVLTLVQFLFASLTFMPPSGASSGSLTSNFDIFQGPAGTPSLGTMIAMDGFCLLFWGLFMWTWAQNFALDLAHVQVAITLGGGGSGKNGGVNALCVGIVLVLHLIRSKGIQDFVIGHLLSAKIVSPDFLSQYSHLMPPEFRRTEPQSSPSWMRSLLAVHILAQAGTAMARRSMAKNRSPAPPRNGKRVDTEASAGSQTQIDSAFESGASVSSYIGADGQLVTPATHKDGRDRLMSAKKRRRQANQVRSRQPFWAALASTKVTVMREYEHSRALNKTGRGLMMTEEDLQGISLDDGLVWITEVDSSTIKFAAGDFSSVDDPALAGVCETARLGNDETEPFYVCVNGALWATATITKVQDAPKGSNTVHWRGEVSGLAPNCAYTCSFVRSDTDEEICVMSVKTPAATDAEQVSSIPTPPQPSYRPSSPTTTLKNSIVNAEVKLNEKRARLRKAKNDHKLVISKIRKELDNYNHRLQSGTDENRQKQRSLQLERNIKQTEEITAALESQLDNLENIPEEELEEWSTQKSKYEQELEQLNLAKEELVSARAAVAREVSSLESELNSAIQRKERLQGRRTRVNEQYERIVSANAQGLNERERRAAEQFAREQDQAKLEANFHEQFASISQSVQEYQVRTNQLWQQAAAIEQAIQQQQQQMLLDSAPLTPEGNLPGTNPLTEAPGMSLGALTTTAPNTRSLLGLSFPSLKSSPLQHASSPVGAASSHPTSPTQPPSYLQHFPTSPLGNTGNYFDMDFTYRDRSFSNRSAHSSLYGADFLDSNRRGPFQLDLSDTVIEKRMDSGSEGVTPNPIMRPISTPFQRADSRGSGSGSGSSGASGSGSGSPSSTGGKGN |
7845 |
1GIZ |
PDB NFT |
NMR STRUCTURE OF AN OLIGONUCLEOTIDE CONTAINING AN ABASIC SITE: ALPHA ANOMER |
>1giz_A mol:na length:13 5'-D(*CP*CP*AP*AP*AP*GP*(D1P)P*AP*CP*TP*GP*GP*G)-3'
CCAAAGXACTGGG
>1giz_B mol:na length:13 5'-D(*CP*CP*CP*AP*GP*TP*AP*CP*TP*TP*TP*GP*G)-3'
CCCAGTACTTTGG |
7846 |
1GJ0 |
PDB NFT |
NMR STRUCTURE OF AN OLIGONUCLEOTIDE CONTAINING AN ABASIC SITE: BETA ANOMER |
>1gj0_A mol:na length:13 5'-D(*CP*CP*AP*AP*AP*GP*(AAB)P*AP*CP*TP*GP*GP*G)-3'
CCAAAGXACTGGG
>1gj0_B mol:na length:13 5'-D(*CP*CP*CP*AP*GP*TP*AP*CP*TP*TP*TP*GP*G)-3'
CCCAGTACTTTGG |
7846 |
Q2UUI0 |
AF NFT |
Probable ubiquitination network signaling protein acrB |
>sp|Q2UUI0|ACRB_ASPOR Probable ubiquitination network signaling protein acrB OS=Aspergillus oryzae (strain ATCC 42149 / RIB 40) OX=510516 GN=acrB PE=3 SV=2 MPRSSATARKSHSNRQENGAAGSGKKVNKQKSNGQLNGNANGSSAPISGPSSQVDWPSSRSNSDTAINSTVATATKANGTTECSKADGNGRGYLNGYVKGNPDMSYGQANGAVPQNGGLTGQASRRTESSKRSGSNTSINPLQLASTILKSCPMYDTIAILIFLLQLPPMVLTLVQFLFASLTFMPPGGASAGSLTSNFDIFQGPAGTPSLGTMIAMDGFFLLFWGLFMWTWAQNFALDLAHVQVAITLGGGGSGKNGGVNTLCVGIVLVLHLIRSKGIQDFVLGHLLSAKVISPDLLSQYSHLLPSEFRRTEPQSSPSWIRSLLAVHILAQAGTAMARRSMAKNRAPAPPRTGKRVDTEASAGSQTQIDSAFESGTSVSSYIGADGQLITPATHKDGRDRLISAKKRRRQANQVRNRQPFWAALASTKVTVMREYEHSRALSKTARGLTMTEEDLQGVSLDDGLVWITDVDSSSIKFAAGDLVSEDAGVSGSCESGRLGEDMEPFYVCVNGALWATVTICKVQDVAKGSSVVHWRGEISGLAPNCAYTCSFLRSDTEEEICVMSVKTPIANDAEQVVSSVSTPPQPSYRPSSPTTTLKNSIVNAELKLNEKRTRLRKAKNDHKLVVSKIRKELDNYNHRLHSGTDENRQKQRSLQLERNIKQTEEATAVLEVQLDNLENIPEEELEEWSAEKAKYEHELELFNSAKEDVATARSAAAREVSQLESDLTSTIQRRERLQGRRTRVNEQYERIISANAQGLNERERRAAEQFAREQDQAKVEANFNEQFASISQSVQEYQLRTNQLWQQCVAIEQALQQQQQQQILLDSAPLTPEGNLPGTNTLSEAPTLSLGALTTSASSNRSLLGLSFPPLKSSPLQHASSPIGPTSSRPTSPTQAPSYLQHFPASPLINTASPFESDFIHRDRSFSNRSGHSSLYGSDFFDSGRRPPFQFDLSEKVVDKRRSSGSESNAPNLGLRPICSPFPRAGSRASGSGSGGSGSGSGSPSSATGKGN |
7846 |
HLA08067 B*58:37 |
HLA NFT |
B*58:37 |
>HLA:HLA08067 B*58:37 181 bp SHSMRYFYTAMSRPGRGEPRFIAVGYVDDTQFVRFDSDAASPRTEPRAPWIEQEGPEYWDGETRNMKASAQTYRENLRIALRYYNQSEAGSHIIQRMYGCDLGPDGRLLRGHDQSAYDGKDYIALNEDLSSWTAADTAAQITQRKWEAARVAEQLRAYLEGECVEWLRRYLENGKETLQRA |
7847 |
HLA08068 B*15:248 |
HLA NFT |
B*15:248 |
>HLA:HLA08068 B*15:248 181 bp SHSMRYFYTAMSRPGRGEPRFIAVGYVDDTQFVRFDSDAASPRMAPRAPWIEQEGPEYWDRETQISKTNTQTYRESLRNLRGYYNQSEAGSHTLQRMYGCDVGPDGRLLRGHDQYAYDGKDYIALNEDLRSWTAADKAAQITQRKWEAAREAEQWRAYLEGLCVEWLRRYLENGKETLQRA |
7847 |
Q0CT23 |
AF NFT |
Probable ubiquitination network signaling protein acrB |
>sp|Q0CT23|ACRB_ASPTN Probable ubiquitination network signaling protein acrB OS=Aspergillus terreus (strain NIH 2624 / FGSC A1156) OX=341663 GN=acrB PE=3 SV=1 MPRSSATARKSHSNRHDNGVVGSGKKVSKQKSNGHLNGNHANSSTPTSGPSSQVDWPSSRSNSDTAIPTTAAAAARLNGATENSKDIRGHLNGYAKGTSDMSYGQANGAVPQNGCLPGDAARRTEKPATASKRSGSSASVNPLHLASTILKSCPMYDTIAILIFLLQLPPMVLTLVQFLFASLTFMPPSGASAGSLTSNFDIFQGPAGTPSLGTMIAMDGFCLLFWGLFMWTWAQNFALDLAHVQVAITLGGGGSGKNGGVNALCVGIVLVLHLIRSKGIQDFVMGHLLSAKIISPDLLSQYSHLIPAEFRRTEPQSSPSWIRSLLAVHILAQAGTAMARRSMAKNRAPAPPRTGKRIDTEASAGSQTQFDSAFESGASMSSYIGPDGQFITPATHKDGRDRLISAKKRRRQANQVRSRQPFWAALASTKVTVMREYEHSRALSKTARGLTMTEDDLQGVSLDDGLVWITDVDSSTIRFAAGDFSSPDDASGSGVCETGRLSDDMEPFYVCVNGAQWATATISKVPDARKGTSAVHWRGEISGLAPNCAYTCSFMRSDTDEEICAMSVKTPATSDAEQVSSISAPPQPTYRPSSPTTTLKNSIINAEAKLNEKRSRMKKAKNDHKLVVSKIRKELENYNHRLHSGTDENRQKQRSLQLERNIKQTEEATAALGEQLDNLENIPEEELEEWTMQKAKYERELELLNSVKEELIAARSAVAREVSSLESELNSTVQRRERLQGRRTRVNEQYERIISANAQGLNERERRAAEQFAREQDQAKLEANFNEQLASITQSIQEYQLRTNQLWQQSAAIEQAIQQQQQQMLMDSAPLTPEGNLPGTNPLGDTPSLALAGLTTSAPSSRSLLGLNFPPLKSSPLQHASSLVGATSSHPASPTQTPSYLQHFPTSPLANASSPFDPDFVYRDRSFSNRSGRSSLYGFDLIDSSRRAPFQFDLSEAASEKRRSSGSESNGPNLGLRPISSPFPRAGSRASGSGSGGSGSGSGSPSSAAGKGI |
7847 |
1GJ1 |
PDB NFT |
NMR structure of d(CCAAAGXACTGGG), X is a 3'phosphoglycolate, 5'phosphate gapped lesion |
>1gj1_A mol:na length:6 5'-D(*CP*CP*AP*AP*AP*G)-3'
CCAAAG
>1gj1_B mol:na length:6 5'-D(P*AP*CP*TP*GP*GP*G)-3'
ACTGGG
>1gj1_C mol:na length:13 5'-D(*CP*CP*CP*AP*GP*TP*AP*CP*TP*TP*TP*GP*G)-3'
CCCAGTACTTTGG |
7848 |
1GJ2 |
PDB NFT |
CO(III)-BLEOMYCIN-OOH BOUND TO AN OLIGONUCLEOTIDE CONTAINING A PHOSPHOGLYCOLATE LESION |
>1gj2_A mol:na length:6 5'-D(*CP*CP*AP*AP*AP*G)-3'
CCAAAG
>1gj2_B mol:na length:6 5'-D(P*AP*CP*TP*GP*GP*G)-3'
ACTGGG
>1gj2_C mol:na length:13 5'-D(*CP*CP*CP*AP*GP*TP*AP*CP*TP*TP*TP*GP*G)-3'
CCCAGTACTTTGG |
7848 |
P31224 |
AF NFT |
Multidrug efflux pump subunit AcrB |
>sp|P31224|ACRB_ECOLI Multidrug efflux pump subunit AcrB OS=Escherichia coli (strain K12) OX=83333 GN=acrB PE=1 SV=1 MPNFFIDRPIFAWVIAIIIMLAGGLAILKLPVAQYPTIAPPAVTISASYPGADAKTVQDTVTQVIEQNMNGIDNLMYMSSNSDSTGTVQITLTFESGTDADIAQVQVQNKLQLAMPLLPQEVQQQGVSVEKSSSSFLMVVGVINTDGTMTQEDISDYVAANMKDAISRTSGVGDVQLFGSQYAMRIWMNPNELNKFQLTPVDVITAIKAQNAQVAAGQLGGTPPVKGQQLNASIIAQTRLTSTEEFGKILLKVNQDGSRVLLRDVAKIELGGENYDIIAEFNGQPASGLGIKLATGANALDTAAAIRAELAKMEPFFPSGLKIVYPYDTTPFVKISIHEVVKTLVEAIILVFLVMYLFLQNFRATLIPTIAVPVVLLGTFAVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVMAEEGLPPKEATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGSTGAIYRQFSITIVSAMALSVLVALILTPALCATMLKPIAKGDHGEGKKGFFGWFNRMFEKSTHHYTDSVGGILRSTGRYLVLYLIIVVGMAYLFVRLPSSFLPDEDQGVFMTMVQLPAGATQERTQKVLNEVTHYYLTKEKNNVESVFAVNGFGFAGRGQNTGIAFVSLKDWADRPGEENKVEAITMRATRAFSQIKDAMVFAFNLPAIVELGTATGFDFELIDQAGLGHEKLTQARNQLLAEAAKHPDMLTSVRPNGLEDTPQFKIDIDQEKAQALGVSINDINTTLGAAWGGSYVNDFIDRGRVKKVYVMSEAKYRMLPDDIGDWYVRAADGQMVPFSAFSSSRWEYGSPRLERYNGLPSMEILGQAAPGKSTGEAMELMEQLASKLPTGVGYDWTGMSYQERLSGNQAPSLYAISLIVVFLCLAALYESWSIPFSVMLVVPLGVIGALLAATFRGLTNDVYFQVGLLTTIGLSAKNAILIVEFAKDLMDKEGKGLIEATLDAVRMRLRPILMTSLAFILGVMPLVISTGAGSGAQNAVGTGVMGGMVTATVLAIFFVPVFFVVVRRRFSRKNEDIEHSHTVDHH |
7848 |
HLA08069 B*15:249 |
HLA NFT |
B*15:249 |
>HLA:HLA08069 B*15:249 181 bp SHSMRYFYTAMSRPGRGEPRFIAVGYVDDTQFVRFDSDAASPRMAPRAPWIEQEGPEYWDRETQISKTNTQTYRESLRNLRGYYNQSEAGSHTLQRMYGCDVGPDGRLLRGHDQSAYDGKDYIALNEDLSSWTAADTAAQITQRKWEAAREAEQWRTYLEGLCVEWLRRYLENGKETLQRA |
7849 |
HLA08070 B*15:250 |
HLA NFT |
B*15:250 |
>HLA:HLA08070 B*15:250 181 bp SHSMRYFYTAMSRPGRGEPRFIAVGYVDDTQFVRFDSDAASPRMAPRAPWIEQEGPEYWDRETQISKTNTQTYRESLRNLRGYYNQSEAGSHIIQRMYGCDVGPDGRLLRGYDQSAYDGKDYIALNEDLSSWTAADTAAQITQRKWEAASEAEQLRAYLEGLCVEWLRRYLENGKETLQRA |
7849 |
Q876Q0 |
AF NFT |
Ubiquitination network signaling protein acrB |
>sp|Q876Q0|ACRB_EMENI Ubiquitination network signaling protein acrB OS=Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) OX=227321 GN=acrB PE=3 SV=1 MPRSSATARKSHSNRQDHGGGGSGKKPSKQKSSGHLNATYNGTAGSETGPSSQVDWPSHRSGDQSIAAAAAKSNGPVDSLKADTNGRGYPGGYAKGNADMSYGQTNGGVSPNGGLAGPASRRTDKSVTGTKRTTSNASVNPFQLASTILRSCPMYDTIAILIFLLQLPPMVLTLVQFLFASLTFMPPSGTASGSFTSNFDIFQGPAGTPSLGTMIAMDGFCLLVWGLFMWTWAQNFALDLAHVQVAITLGGGGAGKNGGVNALCVGIVLILHLIRSKGIQDFVVGHLVSAKIISPDLLSHYSYLMPAEFKRTESQSSPSWIRSLLAVHILAQAGTAMARRSMTKNRTPAPSRSGKRVDTEASAGSQTQIDSAFESAASVSSYLGPDGQIITAAHKDGRDRLISAKKRRRQANQVRSRQPFWAALASTKVTVMREYEHSRALSKTARGLATTEDDLQGVSLDDGLVWITYVDSSTIKFAAGDFASSDDHSASGVCEAGRVSSEDAEPFYVCVNGAPWATVVITKEHDPSKASNTIYWRGEISGLAPNCAYTCSFVKCDTDEEICAMSVKTPAANDAEQANSVPAPPQPSYRPSSPTTTLKNSIINAEAKLNEKRARLRKAKNDHKLAISKIKKELDNYTNRLQSGTDENRQKQRSLQLERNIRQTEEATAALDNQIDNLGNVPDDEYQEWVEQKAKYERELELLKSAKAEIAATRTANARELSSLESELNSTTQRRERLQGRRTRVNEQYERIISANAQGLNERERRAAEQFAREQDQSKLEQSFNEQFASISQSVQDYQLRTSQLWQQCTAVEQALQQQLLMEPAPLTPEGELPGTSTFADAPSVPLGTLASNMPSHRSLLGQSFPPLKSSPLQHYASPIGTAPSHPTSPIAAPSYQPFSSSPFGNAASFLDPDFVYRDRSFSNRSARSSLYGSEFPDAITARRVPFGVDPFELGNEKRRGSGSDSTPLNGPSGLRPISSPFQRAASRASGTGSGGSGGSGSGSGSPSSARGKGN |
7849 |
1GJ4 |
PDB NFT |
SELECTIVITY AT S1, H2O DISPLACEMENT, UPA, TPA, SER190/ALA190 PROTEASE, STRUCTURE-BASED DRUG DESIGN |
>1gj4_L mol:protein length:36 THROMBIN
TFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGR
>1gj4_H mol:protein length:258 THROMBIN
IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG
>1gj4_I mol:protein length:11 ACETYL HIRUDIN
DFEEIPEEYLQ |
7850 |
1GJ5 |
PDB NFT |
SELECTIVITY AT S1, H2O DISPLACEMENT, UPA, TPA, SER190/ALA190 PROTEASE, STRUCTURE-BASED DRUG DESIGN |
>1gj5_L mol:protein length:36 THROMBIN
TFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGR
>1gj5_H mol:protein length:258 THROMBIN
IVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFG
>1gj5_I mol:protein length:11 ACETYL HIRUDIN
DFEEIPEEYLQ |
7850 |
A1CW63 |
AF NFT |
Probable ubiquitination network signaling protein acrB |
>sp|A1CW63|ACRB_NEOFI Probable ubiquitination network signaling protein acrB OS=Neosartorya fischeri (strain ATCC 1020 / DSM 3700 / CBS 544.65 / FGSC A1164 / JCM 1740 / NRRL 181 / WB 181) OX=331117 GN=acrB PE=3 SV=1 MPRSSATARKSHSNRHENGSANTGKKVAKQKSNGHLNGNLNGGSASSSLSSSQVDLPSSRSSSDPVIPTTTATSTKLNGTPDSSKGDCNAPDHLNGYAKGNTDMSYVQNNGVASQTGGDVAGPASRRTEKSATGNKRSPSNASINPLQLASTILKSCPMYDTIAILIFLLQLPPMVLTLVQFLFASLTFLPPSGASAGSLTSNFDIFQGPAGTPSLGTMIAMDGFCLLIWGLFMWTWAQNFALDLAHVQVAITLGGGGFGKNGGVNTLCVGIVLIMHLVRSKGIQDFVIGHLLSSNIISPDMLSQYSHLLPTEFRRTEPQTSPSWLRSLLAVHILAQAGTAMARRSMAKNRTPNPPRTGKRIDTEASAGSQTQIDSAFESGASVSSYIGADGQIVTPAAHKDGRDRLLSAKKRRRQANQVRSRQPFWAALASTKITVMREYEHSRALSKTARGLPMTEDDLQGLSLDDGLVWITEIDSSTIKFAAGDFSSADDSSGSGACEAGCLGSEDMEPFYVCVNGALWATATICKVHDAPKGSSMVHWRGEISGLAPNCAYTCSFVRSDTDEEICVISVKTPATNDAEQVSSVSTPPQPSYRPSSPTTTLKNSIVNAEAKLNEKRSRLRKAKNDHKLVISKIRKELDNYNHRLHSGTDENRQKQRSLQLERNIRQTEEATALLEDQLDNLENVPDEELRKWSDQKAKYEHELGLLNSAKEELASARSAVAREVSSLETELSSAIQRRERLQSRRTRINEQYERIVSANAQGLNERERRAAEQFAREQDQAKLEATFNEQFASIGQSVQEYQLRAQQIWQQCDAIEQAIQQQHQQMLLDPGPLTPEGNLPGTNPFSESALPLGALTSTAPSNRSLLGLSFPPLKSSPLQTASSPVGASSSHPTSPVQQPSYLNFPTSPLVNASSHLDSDFVYRDRSFSNRSARSSLYGSDFMDSSRRQPFQLDLSELLADKRSPGSDSNTALNSGLRPVSSPFQRAGSRGSGSGSNGSGGSGSGSGSPSSVYGKTN |
7850 |
HLA08071 B*15:01:29 |
HLA NFT |
B*15:01:29 |
>HLA:HLA08071 B*15:01:29 181 bp SHSMRYFYTAMSRPGRGEPRFIAVGYVDDTQFVRFDSDAASPRMAPRAPWIEQEGPEYWDRETQISKTNTQTYRESLRNLRGYYNQSEAGSHTLQRMYGCDVGPDGRLLRGHDQSAYDGKDYIALNEDLSSWTAADTAAQITQRKWEAAREAEQWRAYLEGLCVEWLRRYLENGKETLQRA |
7851 |
HLA08072 B*15:251:01 |
HLA NFT |
B*15:251:01 |
>HLA:HLA08072 B*15:251:01 181 bp SHSMRYFYTAMSRPGRGEPRFISVGYVDDTQFVRFDSDAASPRMAPRAPWIEQEGPEYWDRETQISKTNTQTYRESLRNLRGYYNQSEAGSHTLQRMYGCDVGPDGRLLRGHDQSAYDGKDYIALNEDLSSWTAADTAAQITQRKWEAAREAEQWRAYLEGLCVEWLRRYLENGKETLQRA |
7851 |
G3KIM8 |
AF NFT |
Acryloyl-CoA reductase (NADH) |
>sp|G3KIM8|ACRC_ANAPI Acryloyl-CoA reductase (NADH) OS=Anaerotignum propionicum OX=28446 GN=acrC PE=1 SV=1 MFLLKIKKERMKRMDFSLTREQEMLKKLARQFAEIELEPVAEEIDREHVFPAENFKKMAEIGLTGIGIPKEFGGSGGGTLEKVIAVSEFGKKCMASASILSIHLIAPQAIYKYGTKEQKETYLPRLTKGGELGAFALTEPNAGSDAGAVKTTAILDSQTNEYVLNGTKCFISGGGRAGVLVIFALTEPKKGLKGMSAIIVEKGTPGFSIGKVESKMGIAGSETAELIFEDCRVPAANLLGKEGKGFKIAMEALDGARIGVGAQAIGIAEGAIDLSVKYVHERIQFGKPIANLQGIQWYIADMATKTAAARALVEFAAYLEDAGKPFTKESAMCKLNASENARFVTNLALQIHGGYGYMKDYPLERMYRDAKITEIYEGTSEIHKVVIAREVMKR |
7851 |
1GJ6 |
PDB NFT |
ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS |
>1gj6_A mol:protein length:223 BETA-TRYPSIN
IVGGYTCGANTVPYQVSLNSGYHFCGGSLINSQWVVSAAHCYKSGIQVRLGEDNINVVEGNEQFISASKSIVHPSYNSNTLNNDIMLIKLKSAASLNSRVASISLPTSCASAGTQCLISGWGNTKSSGTSYPDVLKCLKAPILSDSSCKSAYPGQITSNMFCAGYLEGGKDSCQGDSGGPVVCSGKLQGIVSWGSGCAQKNKPGVYTKVCNYVSWIKQTIASN |
7852 |
1GJ7 |
PDB NFT |
ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS |
>1gj7_A mol:protein length:23 UROKINASE-TYPE PLASMINOGEN ACTIVATOR
KPSSPPEELKFQCGQKTLRPRFK
>1gj7_B mol:protein length:253 UROKINASE-TYPE PLASMINOGEN ACTIVATOR
IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTICLPSMYNDPQFGTSCEITGFGKEASTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTKEENGLAL |
7852 |
P9WEZ7 |
AF NFT |
Hydrolase acrC |
>sp|P9WEZ7|ACRC_ASPA1 Hydrolase acrC OS=Aspergillus aculeatus (strain ATCC 16872 / CBS 172.66 / WB 5094) OX=690307 GN=acrC PE=2 SV=1 MFKFYPSDFFHFEFLRVLASAPAGGAETGECLAVLPQVPDGDAEAWYRAWTAQAQQARGLGDEALVSGDTVAASGAYLRASNYFRASEFFLHTRPDDPRLLAAMENSVAVFDKGVDLLDTCTVVRVEIPYEEEKGAARLPGRLYLPRSGAAQTGQGQSEDKLPLLIMTGGFDSTQEELYFFGPAAALPRGYAVLTFEGPGQGICLRRDGLRLRPDWEHVTTKVLDVVESQLAKDYPIDLERVAVVGASLGGYFALRAAADPRVRACVSCDACYDLFDVTRSRMPGWFINGWLSRRLSDGFFNWVVNKLAGWSFQLRWEFGHSMWVYGVESPAEVMRCMQQYHARGYLQKVKCSTFVTGAADTFYFTPKQNTEPIFEALGHVPLQKKRLWIGKGVEGGGLQAKIGAWAVFHQKMFVWLDEQFEIKRGTI |
7852 |
HLA08073 B*57:58 |
HLA NFT |
B*57:58 |
>HLA:HLA08073 B*57:58 181 bp SHSMRYFYTAMSRPGRGEPRFISVGYVDDTQFVRFDSDAASPRMAPRAPWIEQEGPEYWDGETRNMKASAQTYRENLRIALRYYNQSEAGSHIIQVMYGCDVGPDGRLLRGHDQSAYDGKDYIALNEDLSSWTAADTAAQITQRKWEAARVAEQLRAYLEGLCVEWLRRYLENGKETLQRA |
7853 |
HLA08074 B*15:252 |
HLA NFT |
B*15:252 |
>HLA:HLA08074 B*15:252 181 bp SHSMRYFYTAMSRPGRGEPRFISVGYVDDTQFVRFDSDAASPREEPRAPWIEQEGPEYWDRNTQICKTNTQTYRESLRNLRGYYNQSEAGSHTLQRMYGCDVGPDGRLLRGHNQYAYDGKDYIALNEDLSSWTAADTAAQITQRKWEAAREAEQLRAYLEGTCVEWLRRYLENGKETLQRA |
7853 |
A0A1L9WQP6 |
AF NFT |
Cytochrome P450 monooxygenase acrD |
>sp|A0A1L9WQP6|ACRD_ASPA1 Cytochrome P450 monooxygenase acrD OS=Aspergillus aculeatus (strain ATCC 16872 / CBS 172.66 / WB 5094) OX=690307 GN=acrD PE=2 SV=1 MAEIHDITGLLKPYLSGTNLVWTLLLVGYIIPKLFQYLQRLFSPVSRIPGSWLHKLTSLPLKIAIAKGESHIFTVDLHKKYGPIVTLSPTMISISDAREIKRIVHTEDWAKSEAVYGNFRQDPQRPTLLAFTDKKAYSQRKRLVSSMFGLRYIRSMQPLMRNCISVLMDELDKQCANGATAVDMQHMIQSLAADIIGVTTFGQTFDLVKNGSHPLPDRLKQALKLSGILQFMPWLTKIPFIPNRDPYVSWFTNEIVAKRRAQIASRQGPPREDLLQKMIEAADESPTSPFRVSDIQDESVVLLIAGSETTANAELFTLIHLLRHPSKLATLYEEIDRWYPRNDPRPTDCDYSMSGMVYLQACIDETMRLVPGQATGSPRESRKDETLLGYDIPKGTTVFPTTQEVHLDETLWPNATEFLPERWLDVYAKGEANSLPYYPFSAGSRVCIGKHFAAQEMHLSLVSLLRRFQFEYVSGQDESTVFRIAQQMRGHRYLMTVGRR |
7853 |
1GJ8 |
PDB NFT |
ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS |
>1gj8_A mol:protein length:23 UROKINASE-TYPE PLASMINOGEN ACTIVATOR
KPSSPPEELKFQCGQKTLRPRFK
>1gj8_B mol:protein length:253 UROKINASE-TYPE PLASMINOGEN ACTIVATOR
IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTICLPSMYNDPQFGTSCEITGFGKEASTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTKEENGLAL |
7854 |
1GJ9 |
PDB NFT |
ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS |
>1gj9_A mol:protein length:23 UROKINASE-TYPE PLASMINOGEN ACTIVATOR
KPSSPPEELKFQCGQKTLRPRFK
>1gj9_B mol:protein length:253 UROKINASE-TYPE PLASMINOGEN ACTIVATOR
IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTICLPSMYNDPQFGTSCEITGFGKEASTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTKEENGLAL |
7854 |
P24177 |
AF NFT |
Probable aminoglycoside efflux pump |
>sp|P24177|ACRD_ECOLI Probable aminoglycoside efflux pump OS=Escherichia coli (strain K12) OX=83333 GN=acrD PE=3 SV=3 MANFFIDRPIFAWVLAILLCLTGTLAIFSLPVEQYPDLAPPNVRVTANYPGASAQTLENTVTQVIEQNMTGLDNLMYMSSQSSGTGQASVTLSFKAGTDPDEAVQQVQNQLQSAMRKLPQAVQNQGVTVRKTGDTNILTIAFVSTDGSMDKQDIADYVASNIQDPLSRVNGVGDIDAYGSQYSMRIWLDPAKLNSFQMTAKDVTDAIESQNAQIAVGQLGGTPSVDKQALNATINAQSLLQTPEQFRDITLRVNQDGSEVRLGDVATVEMGAEKYDYLSRFNGKPASGLGVKLASGANEMATAELVLNRLDELAQYFPHGLEYKVAYETTSFVKASIEDVVKTLLEAIALVFLVMYLFLQNFRATLIPTIAVPVVLMGTFSVLYAFGYSVNTLTMFAMVLAIGLLVDDAIVVVENVERIMSEEGLTPREATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGTTGAIYRQFSITIVAAMVLSVLVAMILTPALCATLLKPLKKGEHHGQKGFFAWFNQMFNRNAERYEKGVAKILHRSLRWIVIYVLLLGGMVFLFLRLPTSFLPLEDRGMFTTSVQLPSGSTQQQTLKVVEQIEKYYFTHEKDNIMSVFATVGSGPGGNGQNVARMFIRLKDWSERDSKTGTSFAIIERATKAFNQIKEARVIASSPPAISGLGSSAGFDMELQDHAGAGHDALMAARNQLLALAAENPELTRVRHNGLDDSPQLQIDIDQRKAQALGVAIDDINDTLQTAWGSSYVNDFMDRGRVKKVYVQAAAPYRMLPDDINLWYVRNKDGGMVPFSAFATSRWETGSPRLERYNGYSAVEIVGEAAPGVSTGTAMDIMESLVKQLPNGFGLEWTAMSYQERLSGAQAPALYAISLLVVFLCLAALYESWSVPFSVMLVVPLGVIGALLATWMRGLENDVYFQVGLLTVIGLSAKNAILIVEFANEMNQKGHDLFEATLHACRQRLRPILMTSLAFIFGVLPMATSTGAGSGGQHAVGTGVMGGMISATILAIYFVPLFFVLVRRRFPLKPRPE |
7854 |
HLA08075 B*15:253 |
HLA NFT |
B*15:253 |
>HLA:HLA08075 B*15:253 181 bp SHSMRYFYTAMSRPGRGEPRFISVGYVDDTQFVRFDSDAASPREEPRAPWIEQEGPEYWDRETQISKTNTQTYRESLRNLRGYYNQSEAGSHTLQRMYGCDVGPDGRLLRGHDQFAYDGKDYIALNEDLSSWTAADTAAQITQRKWEAAREAEQLRAYLEGLCVEWLRRYLENGKETLQRA |
7855 |
HLA08076 B*51:134 |
HLA NFT |
B*51:134 |
>HLA:HLA08076 B*51:134 181 bp SHSMRYFYTAMSRPGRGEPRFIAVGYMDDTQFVRFDSDAASPRTEPRAPWIEQEGPEYWDRNTQIFKTNTQTYRENLRIALRYYNQSEAGSHTWQTMYGCDVGPDGRLLRGHNQYAYDGKDYIALNEDLSSWTAADTAAQITQRKWEAAREAEQLRAYLEGLCVEWLRRHLENGKETLQRA |
7855 |
A0A1L9WQQ1 |
AF NFT |
FAD-binding monooxygenase acrE |
>sp|A0A1L9WQQ1|ACRE_ASPA1 FAD-binding monooxygenase acrE OS=Aspergillus aculeatus (strain ATCC 16872 / CBS 172.66 / WB 5094) OX=690307 GN=acrE PE=2 SV=1 MHRELKEFSHPHGSTGIYEDNLQVDVLIVGAGFSGIYMLHELRKQGLKTVVYEAGSDLGGTWRFNCYPGARVDSQVPLYQFSIPETYKDWTWSTNYPDYKELRAYFDHVDKVLDIKKDVAFGSVVVDAQFDTSQSRWVVKTQDGRTAYAKYFIAAAGVSSKRYIPEWEGIENFKGPIHHTSFWPEHEVDVRGKRAAIIGTGASGVQVTQAWGPQAGHLKVFLRSPNYSIPMRRKELTADEQNQLKPIYPQLFDLREKTFTGALVDFSERSALEDSEAEREAFYEQRYQTGGFDFSTANYKDTMLNPVANRYLYDFWAKKTRARLNDERVKDLLAPVEPPYFFGGKRSSLETDFYEQFNRDTVELVDAKSNPIVGFTENGIKMQDGTVHEVDVVCLATGFDTTTGSMINLGVRSIHGTTLQEDWSQAAETYLGLTVSGYPNLFHLYGTHAPTLFSQAVTTIEVQGRWIVDAIKQMERQAIRSINPSREAAHAWKLQIRAFQNASFFPTVHSTYMGGSIPGKPFELVSYPAGMPMYARQIRDALPTFPGFEVVKADGEKVENLAPGGLEATTNFFERLFGMPPSSAKEDLAKQDH |
7855 |
1GJA |
PDB NFT |
ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS |
>1gja_A mol:protein length:23 UROKINASE-TYPE PLASMINOGEN ACTIVATOR
KPSSPPEELKFQCGQKTLRPRFK
>1gja_B mol:protein length:253 UROKINASE-TYPE PLASMINOGEN ACTIVATOR
IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTICLPSMYNDPQFGTSCEITGFGKEASTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTKEENGLAL |
7856 |
1GJB |
PDB NFT |
ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS |
>1gjb_A mol:protein length:23 UROKINASE-TYPE PLASMINOGEN ACTIVATOR
KPSSPPEELKFQCGQKTLRPRFK
>1gjb_B mol:protein length:253 UROKINASE-TYPE PLASMINOGEN ACTIVATOR
IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTICLPSMYNDPQFGTSCEITGFGKEASTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTKEENGLAL |
7856 |
P24180 |
AF NFT |
Multidrug export protein AcrE |
>sp|P24180|ACRE_ECOLI Multidrug export protein AcrE OS=Escherichia coli (strain K12) OX=83333 GN=acrE PE=1 SV=2 MTKHARFFLLPSFILISAALIAGCNDKGEEKAHVGEPQVTVHIVKTAPLEVKTELPGRTNAYRIAEVRPQVSGIVLNRNFTEGSDVQAGQSLYQIDPATYQANYDSAKGELAKSEAAAAIAHLTVKRYVPLVGTKYISQQEYDQAIADARQADAAVIAAKATVESARINLAYTKVTAPISGRIGKSTVTEGALVTNGQTTELATVQQLDPIYVDVTQSSNDFMRLKQSVEQGNLHKENATSNVELVMENGQTYPLKGTLQFSDVTVDESTGSITLRAVFPNPQHTLLPGMFVRARIDEGVQPDAILIPQQGVSRTPRGDATVLIVNDKSQVEARPVVASQAIGDKWLISEGLKSGDQVIVSGLQKARPGEQVKATTDTPADTASK |
7856 |
HLA08077 B*51:135 |
HLA NFT |
B*51:135 |
>HLA:HLA08077 B*51:135 181 bp SHSMRYFYTAMSRPGRGEPRFIAVGYVDDTQFVRFDSDAASPRTEPRAPWIEQEGPEYWDRNTQIFKTNTQTYRENLRIALRYYNQSEAGSHTLQRMYGCDVGPDGRLLRGHDQYAYDGKDYIALNEDLSSWTAADTAAQITQRKWEAAREAEQLRAYLEGLCVEWLRRHLENGKETLQRA |
7857 |
HLA08078 B*51:136 |
HLA NFT |
B*51:136 |
>HLA:HLA08078 B*51:136 362 bp MRVTAPRTVLLLLWGAVALTETWAGSHSMRYFYTAMSRPGRGEPRFIAVGYVDDTQFVRFDSDAASPRTEPRAPWIEQEGPEYWDRNTQIFKTNTQTYRENLRIALRYYNQSEAGSHTWQTMYGCDVGPDGRLLRGHNQYAYDGKDYIALKEDLSSWTAADTAAQITQRKWEAAREAEQLRAYLEGLCVEWLRRHLENGKETLQRADPPKTHVTHHPVSDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDRTFQKWAAVVVPSGEEQRYTCHVQHEGLPKPLTLRWEPSSQSTIPIVGIVAGLAVLAVVVIGAVVATVMCRRKSSGGKGGSYSQAASSDSAQGSDVSLTA |
7857 |
A0A1L9WQW4 |
AF NFT |
Cytochrome P450 monooxygenase acrF |
>sp|A0A1L9WQW4|ACRF_ASPA1 Cytochrome P450 monooxygenase acrF OS=Aspergillus aculeatus (strain ATCC 16872 / CBS 172.66 / WB 5094) OX=690307 GN=acrF PE=2 SV=1 MHVQSKAPKDLHPQAQMTMLQRLYKLGDMFTVDTWPLMDQMYLVANPKLAHQVSQDSSPFPKHPMITRFLKPLTGYNSVLAANDAKWKELRSLFAPGFSNAHLMTMVPLMVEKTEVFCDLLSEYAAKHELFSMEPMAARLTIDIIGIVVLGVDFKSLTRRDELVEAFRHLLDLLPNGQTLDINPVTHYLRRKYANTMDNYIRRVLRDRAANGANKKFRTLMDIAIERYEQLPNGSLFDCGFEQLAVDNLKTFVFAGHDTSSTTLSNIYHLLSKHPEVLAKVIEEHDQVLGKDTAAIGQLIRDQPSIINKLPYTTAVIRETLRLYPASGSLRMAPKDTTFHPDKAPAVTVPKGSLIWVGIHTIHHDAEFFPCPDEFHPERFMTAKTITLADGRTEAVTAGWNGHAPPADAYRPFEKGPRMCIGSEMAMIEIRVVLAMTLRRFRFESAYAEYRRRHPDEVEAAGGRTEAFGDEAYQVFSSTAKPKSGVPMYVYTKE |
7857 |
1GJC |
PDB NFT |
ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS |
>1gjc_A mol:protein length:23 UROKINASE-TYPE PLASMINOGEN ACTIVATOR
KPSSPPEELKFQCGQKTLRPRFK
>1gjc_B mol:protein length:253 UROKINASE-TYPE PLASMINOGEN ACTIVATOR
IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTICLPSMYNDPQFGTSCEITGFGKEASTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTKEENGLAL |
7858 |
1GJD |
PDB NFT |
ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS |
>1gjd_A mol:protein length:23 UROKINASE-TYPE PLASMINOGEN ACTIVATOR
KPSSPPEELKFQCGQKTLRPRFK
>1gjd_B mol:protein length:253 UROKINASE-TYPE PLASMINOGEN ACTIVATOR
IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVENLILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTICLPSMYNDPQFGTSCEITGFGKEASTDYLYPEQLKMTVVKLISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPWIRSHTKEENGLAL |
7858 |
P24181 |
AF NFT |
Multidrug export protein AcrF |
>sp|P24181|ACRF_ECOLI Multidrug export protein AcrF OS=Escherichia coli (strain K12) OX=83333 GN=acrF PE=1 SV=2 MANFFIRRPIFAWVLAIILMMAGALAILQLPVAQYPTIAPPAVSVSANYPGADAQTVQDTVTQVIEQNMNGIDNLMYMSSTSDSAGSVTITLTFQSGTDPDIAQVQVQNKLQLATPLLPQEVQQQGISVEKSSSSYLMVAGFVSDNPGTTQDDISDYVASNVKDTLSRLNGVGDVQLFGAQYAMRIWLDADLLNKYKLTPVDVINQLKVQNDQIAAGQLGGTPALPGQQLNASIIAQTRFKNPEEFGKVTLRVNSDGSVVRLKDVARVELGGENYNVIARINGKPAAGLGIKLATGANALDTAKAIKAKLAELQPFFPQGMKVLYPYDTTPFVQLSIHEVVKTLFEAIMLVFLVMYLFLQNMRATLIPTIAVPVVLLGTFAILAAFGYSINTLTMFGMVLAIGLLVDDAIVVVENVERVMMEDKLPPKEATEKSMSQIQGALVGIAMVLSAVFIPMAFFGGSTGAIYRQFSITIVSAMALSVLVALILTPALCATLLKPVSAEHHENKGGFFGWFNTTFDHSVNHYTNSVGKILGSTGRYLLIYALIVAGMVVLFLRLPSSFLPEEDQGVFLTMIQLPAGATQERTQKVLDQVTDYYLKNEKANVESVFTVNGFSFSGQAQNAGMAFVSLKPWEERNGDENSAEAVIHRAKMELGKIRDGFVIPFNMPAIVELGTATGFDFELIDQAGLGHDALTQARNQLLGMAAQHPASLVSVRPNGLEDTAQFKLEVDQEKAQALGVSLSDINQTISTALGGTYVNDFIDRGRVKKLYVQADAKFRMLPEDVDKLYVRSANGEMVPFSAFTTSHWVYGSPRLERYNGLPSMEIQGEAAPGTSSGDAMALMENLASKLPAGIGYDWTGMSYQERLSGNQAPALVAISFVVVFLCLAALYESWSIPVSVMLVVPLGIVGVLLAATLFNQKNDVYFMVGLLTTIGLSAKNAILIVEFAKDLMEKEGKGVVEATLMAVRMRLRPILMTSLAFILGVLPLAISNGAGSGAQNAVGIGVMGGMVSATLLAIFFVPVFFVVIRRCFKG |
7858 |
HLA08079 A*31:65 |
HLA NFT |
A*31:65 |
>HLA:HLA08079 A*31:65 337 bp MAVMAPRTLLLLLLGALALTQTWAGSHSMRYFTTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWIEQERPEYWDQETRNVKAHSQIDRVDLGTLRGHYNQSEAGSHTIQMMYGCDVGSDGRFLRGYQQDAYDGKDYIALNEDLRSWTAADMAAQITQRKWEAARVAEQLRAYLEGTCVEWLRRYLENGKETLQRTDPPKTHMTHHAVSDHEATLRCWALSFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWASVVVPSGQEQRYTCHVQHEGLPKPLTLRWEPSSQPTIPIVGIIAGLVLFGAVFAGAVVAAVRWRRKSS |
7859 |
HLA08080 C*04:01:01:05 |
HLA NFT |
C*04:01:01:05 |
>HLA:HLA08080 C*04:01:01:05 366 bp MRVMAPRTLILLLSGALALTETWAGSHSMRYFSTSVSWPGRGEPRFIAVGYVDDTQFVRFDSDAASPRGEPREPWVEQEGPEYWDRETQKYKRQAQADRVNLRKLRGYYNQSEDGSHTLQRMFGCDLGPDGRLLRGYNQFAYDGKDYIALNEDLRSWTAADTAAQITQRKWEAAREAEQRRAYLEGTCVEWLRRYLENGKETLQRAEHPKTHVTHHPVSDHEATLRCWALGFYPAEITLTWQWDGEDQTQDTELVETRPAGDGTFQKWAAVVVPSGEEQRYTCHVQHEGLPEPLTLRWKPSSQPTIPIVGIVAGLAVLAVLAVLGAMVAVVMCRRKSSGGKGGSCSQAASSNSAQGSDESLIACKA |
7859 |
A0A1L9WQN9 |
AF NFT |
O-methyltransferase acrG |
>sp|A0A1L9WQN9|ACRG_ASPA1 O-methyltransferase acrG OS=Aspergillus aculeatus (strain ATCC 16872 / CBS 172.66 / WB 5094) OX=690307 GN=acrG PE=2 SV=1 MSPAKVSANDVPMHGNGFYSSNSALQHSAMLNALPLLAAAAAASKAKQQEEQENSRPFAILEFGSAHGNNSHTPITTVLKSRAPAPSREIHLQFNDRPTNDFSTLATNLTTMTWPVSNAIFTSLLPASFYSRVSPKGSVDVAFSLAALHHLDRVTPVPPEGPIPTHEVRQAEFRAQAHADLLSFLSHRAEEIVPGGGLVLSFVGQELGPNGEEITNYAGPVDACRSAMIDMLQAGVLSPAVANVFEVPAYNRTIADVRRTLAEGEVVAAWEVEEVFERKVVHPALQELEARREAAPGKEEEHAEWYARTVVDWLMAVVAGYFVKAVREGMGVTDQTVLDGLLAEWVERTRGRFLEGHRNEPVECWFVYVRLGRK |
7859 |
1GJE |
PDB NFT |
Peptide Antagonist of IGFBP-1, Minimized Average Structure |
>1gje_A mol:protein length:16 IGFBP-1 antagonist
CRAGPLQWLCEKYFGX |
7860 |
1GJF |
PDB NFT |
Peptide Antagonist of IGFBP1, (i,i+7) Covalently Restrained Analog, Minimized Average Structure |
>1gjf_A mol:protein length:16 IGFBP-1 antagonist
XRAGPLQWLAEKYQGX |
7860 |
P10323 |
AF NFT |
Acrosin |
>sp|P10323|ACRO_HUMAN Acrosin OS=Homo sapiens OX=9606 GN=ACR PE=1 SV=4 MVEMLPTAILLVLAVSVVAKDNATCDGPCGLRFRQNPQGGVRIVGGKAAQHGAWPWMVSLQIFTYNSHRYHTCGGSLLNSRWVLTAAHCFVGKNNVHDWRLVFGAKEITYGNNKPVKAPLQERYVEKIIIHEKYNSATEGNDIALVEITPPISCGRFIGPGCLPHFKAGLPRGSQSCWVAGWGYIEEKAPRPSSILMEARVDLIDLDLCNSTQWYNGRVQPTNVCAGYPVGKIDTCQGDSGGPLMCKDSKESAYVVVGITSWGVGCARAKRPGIYTATWPYLNWIASKIGSNALRMIQSATPPPPTTRPPPIRPPFSHPISAHLPWYFQPPPRPLPPRPPAAQPRPPPSPPPPPPPPASPLPPPPPPPPPTPSSTTKLPQGLSFAKRLQQLIEVLKGKTYSDGKNHYDMETTELPELTSTS |
7860 |
HLA08081 A*02:371 |
HLA NFT |
A*02:371 |
>HLA:HLA08081 A*02:371 181 bp SHSMRYFFTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWIEQEGPEYWDGETRKVKAHSQTHRVDLGTLRGYYNQSEAGSHTVQRMYGCDVGSDWRFLRGYHQYAYDGKDYIALKEDLRSWTAADMAAQTIKHKWEAAHVAEQLRAYLEGTCVEWLRRYLENGKETLQRT |
7861 |
HLA08082 DQB1*06:52 |
HLA NFT |
DQB1*06:52 |
>HLA:HLA08082 DQB1*06:52 183 bp DFVYQFKGMCYFTNGTERVRLVTRHIYNREEYARFDSDVGVYRAVTPQGRPVAEYWNSQKEVLERTRAELDTVCRHNYEVGYRGILQRRVEPIVTISPSRTEALNHHNLLVCSVTDFYPGQIKVQWFRNDQEETAGVVSTPLIRNGDWTFQILVMLEMTPQRGDVYTCHVEHPSLQSPITVEW |
7861 |
Q2UVH8 |
AF NFT |
Acrosin |
>sp|Q2UVH8|ACRO_MELGA Acrosin OS=Meleagris gallopavo OX=9103 GN=ACR PE=1 SV=1 MALLLPLAVLLAACRPGHGFSGGCDTCGLRPVAYHYGGMRVVGGTEALHGSWPWIVSIQNPRFAGTGHMCGGSLITPQWVLSAAHCFGRPNYILQSRVVIGANDLTQLGQEVEVRSIRRAILHEYFNNKTMINDIALLELDRPVHCSYYIQLACVPDPSLRVSELTDCYVSGWGHMGMRSAAPTQTAEVLQEAKVHLLDLNLCNSSHWYDGVLHSHNLCAGYPQGGIDTCQGDSGGPLMCRDSSADYFWLVGVTSWGRGCGRAFRPGIYTSTQHFYNWILLQVRAAAHPTSRTWSHYMSTSSYHHGPNAVPTQPSVSDSCPFPAQKLREFFTGVQNLLQSLWGSKA |
7861 |
1GJG |
PDB NFT |
Peptide Antagonist of IGFBP1, (i,i+8) Covalently Restrained Analog, Minimized Average Structure |
>1gjg_A mol:protein length:14 IGFBP-1 antagonist
XRPLQWLAEKYFQX |
7862 |
1GJH |
PDB NFT |
HUMAN BCL-2, ISOFORM 2 |
>1gjh_A mol:protein length:166 PROTEIN (APOPTOSIS REGULATOR BCL-2 WITH PUTATIVE FLEXIBLE LOOP REPLACED WITH A PORTION OF APOPTOSIS REGULATOR BCL-X PROTEIN)
MAHAGRTGYDNREIVMKYIHYKLSQRGYEWDAGDDVEENRTEAPEGTESEVVHLTLRQAGDDFSRRYRRDFAEMSSQLHLTPFTARGRFATVVEELFRDGVNWGRIVAFFEFGGVMCVESVNREMSPLVDNIALWMTEYLNRHLHTWIQDNGGWDAFVELYGPSMR |
7862 |
P23578 |
AF NFT |
Acrosin |
>sp|P23578|ACRO_MOUSE Acrosin OS=Mus musculus OX=10090 GN=Acr PE=1 SV=1 MVEMLPTVAVLVLAVSVVAKDNTTCDGPCGLRFRQNSQAGTRIVSGQSAQLGAWPWMVSLQIFTSHNSRRYHACGGSLLNSHWVLTAAHCFDNKKKVYDWRLVFGAQEIEYGRNKPVKEPQQERYVQKIVIHEKYNVVTEGNDIALLKITPPVTCGNFIGPCCLPHFKAGPPQIPHTCYVTGWGYIKEKAPRPSPVLMEARVDLIDLDLCNSTQWYNGRVTSTNVCAGYPEGKIDTCQGDSGGPLMCRDNVDSPFVVVGITSWGVGCARAKRPGVYTATWDYLDWIASKIGPNALHLIQPATPHPPTTRHPMVSFHPPSLRPPWYFQHLPSRPLYLRPLRPLLHRPSSTQTSSSLMPLLSPPTPAQPASFTIATQHMRHRTTLSFARRLQRLIEALKMRTYPMKHPSQYSGPRNYHYRFSTFEPLSNKPSEPFLHS |
7862 |
HLA08083 DQB1*02:07:01 |
HLA NFT |
DQB1*02:07:01 |
>HLA:HLA08083 DQB1*02:07:01 261 bp MSWKKALRIPGGLRAATVTLMLSMLSTPVAEGRDSPEDFVYQFKGMCYFTNGTERVRLVSRSIYNREEIVRFDSDVGEFRAVTLLGLPAAEYWNSQKDILERKRAAVDRVCRPNYQLELRTTLQRRVEPTVTISPSRTEALNHHNLLVCSVTDFYPAQIKVRWFRNDQEETAGVVSTPLIRNGDWTFQILVMLEMTPQRGDVYTCHVEHPSLQSPITVEWRAQSESAQSKMLSGIGGFVLGLIFLGLGLIIHHRSQKGLLH |
7863 |
HLA08084 DQB1*03:41 |
HLA NFT |
DQB1*03:41 |
>HLA:HLA08084 DQB1*03:41 183 bp DFVYQFKGMCYFTNGTERVRLVTRYIYNREEYARFDSDVWVYRAVTPLGPPDAEYWNSQKEVLERTRAELDTVCRHNYQLELRTTLQRRVEPTVTISPSRTEALNHHNLLVCSVTDFYPAQIKVRWFRNDQEETTGVVSTPLIRNGDWTFQILVMLEMTPQRGDVYTCHVEHPSLQNPIIVEW |
7863 |
P08001 |
AF NFT |
Acrosin |
>sp|P08001|ACRO_PIG Acrosin OS=Sus scrofa OX=9823 GN=ACR PE=1 SV=5 MLPTAVLLVLAVSVAARDNATCDGPCGLRFRQKLESGMRVVGGMSAEPGAWPWMVSLQIFMYHNNRRYHTCGGILLNSHWVLTAAHCFKNKKKVTDWRLIFGANEVVWGSNKPVKPPLQERFVEEIIIHEKYVSGLEINDIALIKITPPVPCGPFIGPGCLPQFKAGPPRAPQTCWVTGWGYLKEKGPRTSPTLQEARVALIDLELCNSTRWYNGRIRSTNVCAGYPRGKIDTCQGDSGGPLMCRDRAENTFVVVGITSWGVGCARAKRPGVYTSTWPYLNWIASKIGSNALQMVQLGTPPRPSTPAPPVRPPSVQTPVRPPWYFQRPPGPSQQPGSRPRPPAPPPAPPPPPPPPPPPPPPPPPPPQQVSAKPPQALSFAKRLQQLIEALKGTAFSSGRSYYETETTDLQELPAS |
7863 |
1GJI |
PDB NFT |
Crystal structure of c-Rel bound to DNA |
>1gji_C mol:na length:20 IL-2 CD28RE DNA
GGGTTTAAAGAAATTCCAGA
>1gji_D mol:na length:20 IL-2 CD28RE DNA
TCTGGAATTTCTTTAAACCC
>1gji_A mol:protein length:275 C-REL PROTO-ONCOGENE PROTEIN
PYIEIFEQPRQRGMRFRYKCEGRSAGSIPGEHSTDNNKTFPSIQILNYFGKVKIRTTLVTKNEPYKPHPHDLVGKDCRDGYYEAEFGPERRVLSFQNLGIQCVKKKDLKESISLRISKKINPFNVPEEQLHNIDEYDLNVVRLCFQAFLPDEHGNYTLALPPLISNPIYDNRAPNTAELRICRVNKNCGSVKGGDEIFILCDKVQKDDIEVRFVLDNWEAKGSFSQADVHRQVAIVFRTPPFLRDITEPITVKMQLRRPSDQEVSEPMDFRYLPD
>1gji_B mol:protein length:275 C-REL PROTO-ONCOGENE PROTEIN
PYIEIFEQPRQRGMRFRYKCEGRSAGSIPGEHSTDNNKTFPSIQILNYFGKVKIRTTLVTKNEPYKPHPHDLVGKDCRDGYYEAEFGPERRVLSFQNLGIQCVKKKDLKESISLRISKKINPFNVPEEQLHNIDEYDLNVVRLCFQAFLPDEHGNYTLALPPLISNPIYDNRAPNTAELRICRVNKNCGSVKGGDEIFILCDKVQKDDIEVRFVLDNWEAKGSFSQADVHRQVAIVFRTPPFLRDITEPITVKMQLRRPSDQEVSEPMDFRYLPD |
7864 |
1GJJ |
PDB NFT |
N-TERMINAL CONSTANT REGION OF THE NUCLEAR ENVELOPE PROTEIN LAP2 |
>1gjj_A mol:protein length:168 LAP2
MPEFLEDPSVLTKDKLKSELVANNVTLPAGEQRKDVYVQLYLQHLTARNRPPLPAGTNSKGPPDFSSDEEREPTPVLGSGAAAAGRSRAAVGRKATKKTDKPRQEDKDDLDVTELTNEDLLDQLVKYGVNPGPIVGTTRKLYEKKLLKLREQGTESRSSTPLPTISSS |
7864 |
P48038 |
AF NFT |
Acrosin |
>sp|P48038|ACRO_RABIT Acrosin OS=Oryctolagus cuniculus OX=9986 GN=ACR PE=2 SV=1 MLPTAVLLVLVVSVVAKDNATCDGPCGLRFRQNPQGGFRVVGGQAAQQGAWPWMVSLQIFTPRNNRRYHACGGVLLNAHWVLTAAHCFNNKQKVYEWRMVFGAQEIEYGTDKPVRPPLQERYVEKVVTHDQYNYMTEGNDIALLKITPPVPCGPFIGPGCLPNSKAGPPKAAQTCYVAGWGYVKENAPRPSPTLMEARVDLINLELCNSTQWYNGRITASNLCAGYPSGKIDTCQGDSGGPLMCRENQGEPFVVQGITSWGVGCARAKRPGIYTATWPFLDWIASRIGSNALRMIQPATPTPPTTRSPGVHQPPSAHPPWYFQHASGPPHPHPHPHPHPHPRPPQPPAAQAPPPPPPPPPPPPPPPPPPPPPPPPPPPASTKPPQALSFAKRLQQLVEVLKGGSTFSGAKRVDTAAAAAEATEIPEVTLAS |
7864 |
HLA08085 DRB5*02:06 |
HLA NFT |
DRB5*02:06 |
>HLA:HLA08085 DRB5*02:06 183 bp CFLQQDKYECHFFNGTERVRFLHRGIYNQEENVRFDSDVGEYRAVTELGRPDAEYWNSQKDILEQARAAVDTYCRHNYGAVESFTVQRRVEPEVTVYPARTQTLQHHNLLVCSVNGFYPGSIEVRWFRNGQEEKAGVVSTGLIQNGDWTFQILVMLETVPRSGEVYTCQVEHPSVTSPLTVEW |
7865 |
HLA08086 DRB1*14:126:01 |
HLA NFT |
DRB1*14:126:01 |
>HLA:HLA08086 DRB1*14:126:01 89 bp RFLEYSTGECYFFNGTERVRFLDRYFHNQEEFVRFDSDVGEYRAVTELGRPDAEYWNSQKDLLERRRAEVDTYCRHNYGVVESFTVQRR |
7865 |
P29293 |
AF NFT |
Acrosin |
>sp|P29293|ACRO_RAT Acrosin OS=Rattus norvegicus OX=10116 GN=Acr PE=2 SV=2 MVEMLPTVVALVLAVSVVAKDNTTCDGPCGLRFRQNPQAGIRIVGGQTSSPGAWPWMVSLQIFTSHNSRRYHACGGSLLNSHWVLTAAHCFDNKKKVYDWRLVFGAHEIEYGRNKPVKEPQQERYVQKIVIHEKYNAVTEGNDIALLKVTPPVTCGDFVGPGCLPHFKSGPPRIPHTCYVTGWGYIKDNAPRPSPVLMEARVDLIDLDLCNSTQWYNGRVTSTNVCAGYPEGKIDTCQGDSGGPLMCRDSVDSPFVIVGITSWGVGCARAKRPGVYTATWDYLDWIASKIGPTALHLIQPATPHPPTTQQPVISFHPPSIHPPWYFQHLSPRPPHLRPPRPLLHQPSSVHTSSAPVIPLLSLLTPVQPVSFTLAAYHTRHHTTLSFARRLQHLIEALKMRTYPIKYPSRYSGPVNYQHRFSTFEPLSNKPSEPLLHS |
7865 |
1GJM |
PDB NFT |
Covalent attachment of an electroactive sulphydryl reagent in the active site of cytochrome P450cam |
>1gjm_A mol:protein length:414 CYTOCHROME P450-CAM
TTETIQSNANLAPLPPHVPEHLVFDFDMYNPSNLSAGVQEAWAVLQESNVPDLVWTRCNGGHWIATRGQLIREAYEDYRHFSSECPFIPREAGEAYDFIPTSMDPPEQRQFRALANQVVGMPVVDKLENRIQELACSLIESLRPQGQCNFTEDYAEPFPIRIFMLLAGLPEEDIPHLKYLTDQMTRPDGSMTFAEAKEALYDYLIPIIEQRRQKPGTDAISIVANGQVNGRPITSDEAKRMCGLLLVGGLDTVVNFLSFSMEFLAKSPEHRQELIERPERIPAACEELLRRFSLVADGRILTSDYEFHGVQLKKGDQILLPQMLSGLDERENAAPMHVDFSRQKVSHTTFGHGSHLCLGQHLARREIIVTLKEWLTRIPDFSIAPGAQIQHKSGIVSGVQALPLVWDPATTKAV |
7866 |
1GJN |
PDB NFT |
Hydrogen Peroxide Derived Myoglobin Compound II at pH 5.2 |
>1gjn_A mol:protein length:153 MYOGLOBIN
GLSDGEWQQVLNVWGKVEADIAGHGQEVLIRLFTGHPETLEKFDKFKHLKTEAEMKASEDLKKHGTVVLTALGGILKKKGHHEAELKPLAQSHATKHKIPIKYLEFISDAIIHVLHSKHPGDFGADAQGAMTKALELFRNDIAAKYKELGFQG |
7866 |
Q9GL10 |
AF NFT |
Acrosin (Fragment) |
>sp|Q9GL10|ACRO_SHEEP Acrosin (Fragment) OS=Ovis aries OX=9940 GN=ACR PE=1 SV=1 MLPTAVLLVLAVSVVARDNTTCDGPCGVRFRQNRQGGVRIIGGQDAAHGAWPWMVSLQIFTYHNNRRYHVCGGSLLNSQWLLTAAHCFRIKKKVTDWRLIFGAKEVEWGTNKPVKPPLQERYVEKIIIHEKYSASSEANDIALMKITPPVTCGHFIGPGCLPQFRAGPPRVPQTCWVAGWGFLQENARRTSPMLQEARVDLIDLGLCNSTRWYNGRIRSTNVCAGYPEGKIDTCQGDSGGPLMCKDSAENSYVVVGITSWGVGCARAKRPGVYTSTWSYLNWIASKIGSTAVHMIQLPTASPASTPGAQASSGSVQPSVRPPWFFQQIT |
7866 |
HLA08087 A*29:39 |
HLA NFT |
A*29:39 |
>HLA:HLA08087 A*29:39 365 bp MAVMAPRTLLLLLLGALALTQTWAGSHSMRYFTTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDAASQRMEPRAPWIEQEGPEYWDLQTRNVKAQSQIDRVDLGTLRGYYNQSEAGSHTIQMMYGCDVGSDGRFLRGYRQDAYDGKDYIALNEDLRSWTAADMAAQITQRKWEAARVAEQLRAYLEGTCVEWLRRYLENGKETLQRTDAPKTHMTHHAVSDHEATLRCWALSFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWASVVVPSGQEQRYTCHVQHEGLPKPLTLRWEPSSQPTIPIVGIIAGLVLFGAVFAGAVVAAVRWRRKSSDRKGGSYSQAASSDSAQGSDMSLTACKV |
7867 |
HLA08088 C*08:63 |
HLA NFT |
C*08:63 |
>HLA:HLA08088 C*08:63 365 bp MRVMAPRTLILLLSGALALTETWACSHSMRYFYTAVSRPGRGEPRFIAVGYVDDTQFVQFDSDAASPRGEPRAPWVEQEGPEYWDRETQKYKRQAQTDRVSLRNLRGYYNQSEAGSHTLQRMYGCDLGPDGRLLRGYNQFAYDGKDYIALNEDLRSWTAADKAAQITQRKWEAACEAEQRRAYLEGTCVEWLRRYLENGKKTLQRAEHPKTHVTHHPVSDHEATLRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDGTFQKWAAVVVPSGEEQRYTCHVQHEGLPEPLTLRWGPSSQPTIPIVGIVAGLAVLAVLAVLGAVMAVVMCRRKSSGGKGGSCSQAASSNSAQGSDESLIACK |
7867 |
A0A1L9WQN2 |
AF NFT |
Acurin A biosynthesis cluster transcription regulator |
>sp|A0A1L9WQN2|ACRR_ASPA1 Acurin A biosynthesis cluster transcription regulator OS=Aspergillus aculeatus (strain ATCC 16872 / CBS 172.66 / WB 5094) OX=690307 GN=acrR PE=3 SV=1 MSPNMSLTASHPQQPQPTPQSKAQLTRQACNRCHASKLKCLRPPGVTTSKSCIRCIKADTECVYDPPQRFGRPRQKSRPQPESVPPRIEAREPEVTDPRRARHGSTIGARWESSERESNGSLAPSSAAESPYTAAESPDNRSSAAVAAAPLVGMDYASSHFPEPLESERTSELLDAFQSESMQLDVDSYWGETDPVMPPAATVPYSDLLTGPIDLDFTVSDQDDRAKIPKHALDPALSGADTGSTADDYVLDLVQLQASVNQNNRELAAMIRKAQSALGMSDGRVGQALPIPDSQFKTHLQRNLKASEQTLDVLHRINSQFAPVSRETRPPSRSYGLDPTLDRLYADCVSQDHAFGVGGDELGVRATTPPGVSAADPQHSILAFLVLTTYLRLLHNFDALISILQDRLRCSASLDPRRPLHLSEDISASDSSSNPLLDVSLGSFSFSSSSARSLQAMLNVQMINTVLTKIKSSTQRMLLGPDYLPPSSCSSSASTSSTASTTSCSTRAPPSSATGGAHHPATAGSIFFHHAHSHSHSSSDHLFSQPEGRGYAPYNHAFHPPPPSRHTHNYPTPETITPPSSVLGGVSGTTPPPFVSGVDHVVRRALTEVQELELSLRNRARAIQQWSEEGF |